6 Matching Annotations
  1. Oct 2025
    1. Author Response

      The following is the authors’ response to the original reviews.

      We thank the reviewers for their positive and constructive evaluations. Based upon the reviewers’ helpful comments, we have performed complementary experiments. In particular, we additionally show that:

      • a complete analysis of CXCR1/2 binding chemokines in the secretions of tissular CD8+ T cells reinforces the key role of CXCL8 in CD8+ T cell-induced fibrocyte chemotaxis (new panel D in Figure 2)

      • a direct contact between fibrocytes and CD8+ T cells triggers CD8+ T cell cytotoxicity against primary basal bronchial epithelial cells (new Figure 6)

      • the interaction between CD8+ T cells and fibrocytes is bidirectional, with CD8+ T cells triggering the development of fibrocyte immune properties (new Figure 7)

      • the characteristic time to reach a stationary state reminiscent of a resolution of the COPD condition was estimated to be about 2.5 years using the simulations. Interfering with chemotaxis and adhesion processes by inhibiting CXCR1/2 and CD54, respectively was not sufficient to reverse the COPD condition, as predicted by the mathematical model (new Figure 9)

      • the massive proliferation effect induced by fibrocytes is specific to CD8+ T cells and not CD4+ T cells (new Figure 3-figure supplement 2), and that fibrocytes moderately promote the death of unactivated CD8+ T cells in direct co-culture (new Figure 3-figure supplement 3)

      We have graphically summarized our findings (new Figure 10) suggesting the existence of a positive feedback loop playing a role in the vicious cycle that promotes COPD. A new table describing patient characteristics for basal bronchial epithelial cell purification has also been added (new Supplementary File 9), the Supplementary Files 7 and S8 have been up-dated to take into account the new experiments.

      The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD041402.  

      Reviewer #1 (Recommendations For The Authors):

      The experimental approaches are all rationally designed and the data clearly presented, with appropriate analyses and sample sizes. I could find no technical or interpretative concerns. The interrelationship between the observational data (histology) with the quantitative live cell imaging and the follow-on functional investigations is especially laudable. The data nicely unifies several years of accumulated data regarding the (separate) participation of CD8 T cells and fibrocytes in COPD.

      We thank the reviewer for his/her comments.

      I have only minor comments:

      1) Line 79: The observation that T cells may influence fibrocyte differentiation/function was initially made some years earlier by Abe et al (J Immunol 2001; 7556), and should be cited in addition to the follow-on work of Niedermeyer.

      This reference has been added to acknowledge this seminal work.

      2) Line 632: Corticosteroids originate from the cortex of the adrenal gland. Budenoside and fluticasone are glucocorticoids, not corticosteroids.

      This mistake has been corrected in the discussion of the revised manuscript (see line 802 in the revised manuscript).

      3) Given the state of T cell immunotherapies, cytokine/chemokine antagonists, and emerging fibrocyte-targeted drugs, can the authors possibly speculate as to desired pathways to target therapeutically?

      Chemokine-receptor based therapies could be used to inhibit fibrocyte recruitment into the lungs, such as CXCR4 blockade. We have very recently shown that using the CXCR4 antagonist, plerixafor, alleviates bronchial obstruction and reduces peri-bronchial fibrocytes density (Dupin et al., 2023). Because CXCR4 expression in human fibrocytes is dependent on mTOR signaling and is inhibited by rapamycin in vitro (Mehrad et al., 2009), alternative strategies consisting of targeting fibrocytes via mTOR have been proposed. This target has proven effective in bronchiolitis obliterans, idiopathic pulmonary fibrosis, and thyroid-associated ophthalmopathy, using rapamycin (Gillen et al., 2013; Mehrad et al., 2009), sirolimus (Manjarres et al., 2023) or an insulin-like growth factor-1 (IGF-I) receptor blocking antibody (Douglas et al., 2020; Smith et al., 2017). Inhibiting mTOR is also expected to have effects on CD8+ T cells, ranging from an immunostimulatory effect by activation of memory CD8+ T-cell formation, to an immunosuppressive effect by inhibition of T cell proliferation (Araki et al., 2010). Last, chemokine-receptor base therapies could also include strategies to inhibit the CD8+-induced fibrocyte chemotaxis, such as dual CXCR1-CXCR2 blockade. We were able to test this latter strategy in our mathematical model, see response to point 6 of reviewer 2.

      Immunotherapies directly targeting the interaction between fibrocytes and CD8+ T cells could also be considered, such as CD86 or CD54 blockade. The use of abatacept and belatacept, that interfere with T cell co-stimulation, is effective in patients with rheumatoid arthritis (Pombo-Suarez & Gomez-Reino, 2019) and in kidney-transplant recipients (Vincenti et al., 2016), respectively. Targeting the IGF-I receptor by teprotumumab in the context of thyroid-associated ophthalmopathy also improved disease outcomes, possibly by altering fibrocyte-T cell interactions (Bucala, 2022; Fernando et al., 2021).

      We also tested this CD86 and CD54 blocking strategy for COPD treatment by simulations, see response to point 6 of reviewer 2.

      However, such therapies should be used with caution as they may favour adverse events such as infections, particularly in the COPD population (Rozelle & Genovese, 2007). Additionally, the fibrocytes-lymphocytes interaction has recently been shown to promote anti-tumoral immunity via the PD1-PDL1 immunological synapse (Afroj et al., 2021; Mitsuhashi et al., 2023). Therefore, care should be taken in the selection of patients to be treated and/or timing of treatment administration with regards to the increased risk of lung cancer in COPD patients.

      The discussion section has been altered accordingly.

      4) The authors may want to consider mentioning (and citing) recent insight into the immune-mediated fibrosis in thyroid-associated ophthalmopathy

      These important publications are now cited in a dedicated paragraph about the possible therapeutical interventions (see answer to point 3, and discussion in the revised manuscript).

      Reviewer #2 (Recommendations For The Authors):

      Specific comments

      1) The rationale for the selection of chemokines overexpressed by CD8+ T cells in COPD is based on literature data of n=2 patients per group. This is limited and risky. I am less concerned about false positives given the selection of chemokines and the available literature but am worried about the possibility that many chemokines may not have been selected based on insufficient power to do meaningful stats on this comparison. For example, many other CXCR1/2 binding CXCL chemokines exist and these could contribute to the migration effect in Fig 2C as well. Given the currently available single-cell resources it should be possible to extend these observations and to investigate CXCL chemokine expression in COPD CD8 T cells to the benefit of Fig 2A in full detail.

      We agree with the reviewer that the rationale for the selection of chemokines of interest could be reinforced by the analysis of supplementary single-cell resources. We used data from the COPD cell atlas (Gene Expression Omnibus GSE136831 (Sauler et al., 2022)) to perform such an analysis of chemokine expression by CD8+ CD103+ and CD8+ CD103- T cells. However, the expression level of all chemokines was globally very low, and was not different between control and COPD patients (see Author response image 1).

      Author response image 1.

      Expression of CXC chemokines in lung CD8+ CD103+ and CD8+ CD103- T cells from patients with COPD (n=18 independent samples) in comparison with healthy control subjects (n=29 independent samples) under resting conditions by Single-Cell RNA sequencing analysis (GEO accession GSE136831). The heatmaps show the normalized expression of genes (horizontal axes) encoding CXC chemokines. PF4=CXCL4, PPBP= CXCL7.

      The latter results are in discrepancy with those resulting from transcriptomic analysis of microarray data obtained on purified lung CD8+ CD103+ and CD8+ CD103- T cells, showing a significant level of chemokines expression (Hombrink et al., 2016), and a differential expression of CCL2, CCL26, CXCL2, CXCL8 and CCL3L1 between CD8+ T lymphocytes of control and COPD patients (Figure 2A in the revised manuscript). The reason for these differences is unclear, and could be attributed to biological differences (samples obtained from different patients) or, more likely, to differences in sample processing (cell sorting by flow cytometry for microarray analysis, that could activate minimally CD8+ cells) and/or methodological differences (differences of sensitivity between microarray and scRNA seq).

      Nevertheless, microarray data regarding CXCL8 expression are in good agreement with our in vitro experiments, showing an enhanced CXCL8 expression by CD8+ T cells purified from COPD lungs, in comparison with that of control subjects. In addition, the CXCL8 blocking antibody fully abrogates the increase of migration induced by secretion of COPD CD8+ T cells, to the same extent as the blocking of CXCR1/2 by reparixin. This suggests that this supplementary chemotaxis is mainly due to CXCL8 and not other CXCR1/2 binding CXCL chemokines, and correlates CXCL8 measurements to functional experiments. This precision has been now added in the results section of the revised version.

      2) Equally, it would strengthen the work if multiplex ELISA assays could be provided on the supernatants used in Fig 2D to provide a more comprehensive view of CXCR1/2 binding chemokines.

      In order to have a complete view of CXCR1/2 binding chemokines, we have now performed supplementary ELISA assays to measure the concentrations of CXCL1, 3, 5, 6 and 7, in addition of the measurements of CXCL2 and CXCL8 already presented in the previous version of the manuscript (Figure 2D). Results of these new assays are now presented in the revised version of Figure 2. Concentrations of CXCL1, 3, 5, 6 and 7 were unchanged between the control and COPD conditions.

      3) In the functional analyses, I missed information on the activation of the fibrocytes. Equally, the focus on CD8 T cells was mainly on proliferation in the functional work. RNAseq analyses on the cells, comparing CD8 T cells and fibrocytes, alone and in co-culture to each other would help to identify interaction patterns in comprehensive detail. Such an experiment would bolster the significance of the studies by providing impact analysis not only on the T cells beyond proliferation but by expanding on the effect of the interaction on the fibrocyte as well.

      Regarding the activation state of fibrocytes, we apologize if this was not clear: in our in vitro co-culture experiments, we chose not to activate the fibrocytes. This setting is in agreement with previous findings, demonstrating an antigen-independent T cell proliferation effect driven by fibrocytes (Nemzek et al., 2013), and it is now explicitly written in the results of the revised manuscript.

      Regarding the focus of the functional analyses:

      First, we have pushed forward the analysis of the consequences of the interaction beyond CD8+ T cells proliferation. In particular, having shown that fibrocytes promote CD8+ T cells expression of cytotoxic molecules such as granzyme B, we decided to investigate the cytotoxic capacity of CD8+ T cells against primary basal bronchial epithelial cells (see new Supplementary File 9 in the revised manuscript for patient characteristics).

      Direct co-culture with fibrocytes increased total and membrane expression of the cytotoxic degranulation marker CD107a, which was only significant in non-activated CD8+ T cells (see new Figure 6A-E in the revised manuscript). A parallel increase of cytotoxicity against primary epithelial cells was observed in the same condition (see new Figure 6F-H in the revised manuscript). This demonstrates that following direct interaction with fibrocytes, CD8+ T cells have the ability to kill target cells such as bronchial epithelial cells. This is now included in the results section of the revised manuscript.

      Second, we have now performed proteomic analyses on fibrocytes, alone or in co-culture during 6 days with CD8+ T cells either non-activated or activated (see new Figure 7A in the revised manuscript). Of the top ten pathways that were most significantly activated in co-cultured vs mono-cultured fibrocytes, largest upregulated genes were those of the dendritic cell maturation box, the multiple sclerosis signaling pathway, the neuroinflammation signaling pathway and the macrophage classical signaling pathway, irrespective of the activation state of CD8+ T cells (see new Figure 7B in the revised manuscript). The changes were globally identical in the two conditions of CD8+ T cell activation, with some upregulation more pronounced in the activated condition. They were mostly driven by up-regulation of a core set of Major Histocompatibility Complex class I (HLA-B, C, F) and II (HLA-DMB, DPA1, DPB1, DRA, DRB1, DRB3) molecules, co-simulatory and adhesion molecules (CD40, CD86 and CD54). Another notable proteomic signature was that of increased expression of IFN signaling-mediators IKBE and STAT1, and the IFN-responsive genes GBP2, GBP4 and RNF213. We also observed a strong downregulation of CD14, suggesting fibrocyte differentiation, and an upregulation of the matrix metalloproteinase-9 (MMP9) in the non-activated condition only. Altogether, these changes suggest that the interaction between CD8+ T cells and fibrocytes promotes the development of fibrocyte immune properties, which could subsequently impact the activation of CD4+ T cells activation.

      Up-regulated pathways identified in proteomic profile of fibrocytes co-cultured with CD8+ T cells are very consistent with a shift towards a proinflammatory phenotype rather than towards a reparative role. The activation of IFN-γ signaling could be triggered by CD8+ T cell secretion of IFN upon fibrocyte interaction, suggesting the existence of a positive feedback loop (see new Figure 10). Additionally, the priming of fibrocytes by CD8+ T cells could also induce CD4+ T cell activation.

      4) I suggest rewording the abstract to capture the main storyline and wording more. The abstract is good, but I see so many novelties in the paper that are not well sold in the abstract, particularly the modelling aspects.

      As suggested by the reviewer, we revised the abstract, as shown below and in the revised manuscript. The changes are indicated in red:

      Revised abstract:

      Bronchi of chronic obstructive pulmonary disease (COPD) are the site of extensive cell infiltration, allowing persistent contacts between resident cells and immune cells. Tissue fibrocytes interaction with CD8+ T cells and its consequences were investigated using a combination of in situ, in vitro experiments and mathematical modeling. We show that fibrocytes and CD8+ T cells are found in vicinity in distal airways and that potential interactions are more frequent in tissues from COPD patients compared to those of control subjects. Increased proximity and clusterization between CD8+ T cells and fibrocytes are associated with altered lung function. Tissular CD8+ T cells from COPD patients promote fibrocyte chemotaxis via the CXCL8-CXCR1/2 axis. Live imaging shows that CD8+ T cells establish short-term interactions with fibrocytes, that trigger CD8+ T cell proliferation in a CD54- and CD86-dependent manner, pro-inflammatory cytokines production, CD8+ T cell cytotoxic activity against bronchial epithelial cells and fibrocyte immunomodulatory properties. We defined a computational model describing these intercellular interactions and calibrated the parameters based on our experimental measurements. We show the model’s ability to reproduce histological ex vivo characteristics, and observe an important contribution of fibrocyte-mediated CD8+ T cell proliferation in COPD development. Using the model to test therapeutic scenarios, we predict a recovery time of several years, and the failure of targeting chemotaxis or interacting processes. Altogether, our study reveals that local interactions between fibrocytes and CD8+ T cells could jeopardize the balance between protective immunity and chronic inflammation in bronchi of COPD patients.

      5) The probabilistic model appears to suggest that reduced CD8 T cell death may also explain the increase in the pathology in COPD. Did the authors find that fibrocytes reduce cell death of the CD8 T cells?

      Taking advantage of the staining of CD8+ T cells with the death marker Zombie NIR™, we have quantified CD8+ T cell death in our co-culture assay. The presence of fibrocytes in the indirect co-culture assay did not affect CD8+ T cell death (see new Figure 3-figure supplement 3A-B in the revised manuscript). In direct co-culture, the death of CD8+ T cells was significantly increased in the non-activated condition but not in the activated condition (see new Figure 3-figure supplement 3C-D in the revised manuscript). Of note, these results are in agreement with a recent study showing the existence of CD8+ T cell-population-intrinsic mechanisms regulating cellular behavior, with induction of apoptosis to avoid an excessive increase in T cell population (Zenke et al., 2020). This is taken into account in our mathematical model by an increased probability p_(dC+) of dying when a CD8+ T cell is surrounded by many other T cells in its neighborhood. It also suggests that the reduced CD8+ T cell death evidenced in tissues from patients with COPD (Siena et al., 2011) might not be due to the specific interplay between fibrocyte and CD8+ T cells, but rather to a global pro-survival environment in COPD lungs.

      These new data have been described in the results section.

      6) Following the modeling in Figure 6, curiosity came to mind, which is how long it would take for the pathology to disappear if a drug would be applied to the patient. How much should the interactions be reduced and how long would it take to reach clinical benefit? Could such predictions be made? I understand that this may be outside the main message of the manuscript but perhaps this could be included in the discussion.

      This is a very interesting question, that we have addressed by performing additional simulations to investigate the outcomes of possible therapeutic interventions. First, we applied a COPD dynamics during 20 years, to generate the COPD state, that provide the basis for treatment implementation. Then, we applied a COPD dynamic during 7 years, that mimics the placebo condition (see new Figure 9A in the revised manuscript, and below), that we compared to a control dynamics (“Total inhibition”), that mimics an ideal treatment able to restore all cellular processes. As expected the populations of fibrocytes and CD8+ T cells, as well as the density of mixed clusters, decreased. These numbers reached levels similar of healthy subjects after approximately 2.5 years, and this time point can therefore be considered as the steady state (Figure 9B-E).

      Monitoring of the different processes revealed that these effects were mainly due to a reduction in fibrocyte-induced CD8+ T duplication, and a transient or more prolonged increase in basal fibrocyte and CD8+ T death (Figure 9C-D).

      Then, three possible realistic treatments were considered (Figure 9A). We tested the effect of directly inhibiting the interaction between fibrocytes and CD8+ T cells by blocking CD54. This was implemented in the model by altering the increased probability of a CD8+ T cell to divide when a fibrocyte is in its neighbourhood, as shown by the co-culture results (Figure 4). We also chose to reflect the effect of a dual CXCR1/2 inhibition by setting the displacement function of fibrocyte similar to that of control dynamics, in agreement with the in vitro experiments (Figure 2E). Blocking CD54 only slightly reduced the density of CD8+ T cells compared to the placebo condition, and had no effect on fibrocyte and mixed cluster densities (Figure 9B). CXCR1/2 inhibition was a little bit more potent on the reduction of CD8+ T cells than CD54 inhibition, and it also significantly decreased the density of mixed clusters (Figure 9B). As expected, this occurred through a reduction of fibrocyte-induced duplication, which was affected more strongly by CXCR1/2 blockage than by CD54 blockage (Figure 9C-E). Combining both therapies (CD54 and CXCR1/2 inhibition) did not strongly major the effects (Figure 9B-E). In all the conditions tested, the size of the fibrocyte population remained unchanged, suggesting that other processes such as fibrocyte death or infiltration should be targeted to expect broader effects.

      The results section has been altered accordingly.

      Using the simulations, we were also able to estimate the characteristic time to reach a stationary state reminiscent of a resolution of the COPD condition. This time of approximately 2.5 years was totally unpredictable by in vitro experiments, and indicates that a treatment aiming at restoring these cellular processes should be continued during several years to obtain significant changes.

      We have also investigated the outcomes of more realistic treatments, modifying specifically processes such as chemotaxis or targeting directly the intercellular interactions. The modification of parameters controlling these processes only slightly affected the final state, suggesting that such treatments may be more effective when used in combination with other drugs e.g. those affecting fibrocyte infiltration and/or death.

      The discussion section has been altered accordingly.

      Reviewer #3 (Recommendations For The Authors):

      1) Broader assessment of cell types in the lung: Staining for other cell types such as dendritic cells, CD4 cells, and interstitial macrophages, and comparing their proximity to fibrocytes with that of CD8 cells would better justify the CD8 focus.

      We agree with the reviewer that multiple stainings would have better justified the focus on CD8+ T cells. However, it is difficult to distinguish fibrocytes, dendritic cells and interstitial macrophages on the basis of immunohistochemistry, as we and others previously showed (Dupin et al., 2019; Mitsuhashi et al., 2015; Pilling et al., 2009). On the other hand, the study of Afroj et al. indicated the possible interaction between fibrocytes and CD8+ T cells in cancer context, with the induction of CD8+ T cell proliferation (Afroj et al., 2021). This T cell-costimulatory function of fibrocytes and CD8+ T cells was further confirmed in a very recent study, together with the antitumor effects of PD-L1 and VEGF blockade (Mitsuhashi et al., 2023). These data, along with the specific implication on CD8+ T cells in COPD, relying mainly on their abundance in COPD bronchi (O’Shaughnessy et al., 1997), their overactivation state (Roos-Engstrand et al., 2009), their cytotoxic phenotype (Freeman et al., 2010; Wang et al., 2020) and the protection against lung inflammation and emphysema induced by their depletion (Maeno et al., 2007) justified the CD8 focus.

      To further justify this focus, we have now performed co-culture between fibrocytes and CD4+ T cells, indicating that the massive fibrocyte-mediated proliferation was specific to CD8+ T cells (see answer to comment 3 below). This is in agreement with the results obtained with the simulations, showing that considering fibrocytes and CD8+ T cells only was sufficient to reproduce the spatial patterns in the bronchi of healthy and COPD patients. Altogether, we think that focusing on the CD8+ T cell-fibrocyte interplay was pertinent in the context of COPD. It does obviously not exclude the possibility of other interactions, that could be the focus of other studies.

      2) Transcriptomic analysis: Using n=2 and only showing the chemokines as well as selected adhesion receptor data narrows the focus but does not provide broader insights into the interactions. Using a more robust sample size and performing a comprehensive pathway analysis would represent an unbiased analysis to determine the most dysregulated pathways. Importantly, the authors could use a single-cell RNA-seq dataset to broadly assess the transcriptomes of several cell types in the lung (such as the data from (Sauler et al, Characterization of the COPD alveolar niche using single-cell RNA sequencing).

      This very pertinent suggestion has also been raised by reviewer 2, see our answer to comment 1 of reviewer 2, and below:

      We agree with the reviewer that the rationale for the selection of chemokines of interest could be reinforced by the analysis of supplementary single-cell resources. We used data from the COPD cell atlas (Gene Expression Omnibus GSE136831 (Sauler et al., 2022)) to perform such an analysis of chemokine expression by CD8+ CD103+ and CD8+ CD103- T cells. However, the expression level of all chemokines was globally very low, and was not different between control and COPD patients (see Figure scRNAseq, in the answer to comment 1 of reviewer 2).

      These latter results are in discrepancy with those resulting from transcriptomic analysis of microarray data obtained on purified lung CD8+ CD103+ and CD8+ CD103- T cells, showing a significant level of chemokines expression (Hombrink et al., 2016), and a differential expression of CCL2, CCL26, CXCL2, CXCL8 and CCL3L1 between CD8+ T lymphocytes of control and COPD patients (Figure 2A in the revised manuscript). The reason for these differences is unclear, and could be attributed to biological differences (samples obtained from different patients) or, more likely, to differences in sample processing (cell sorting by flow cytometry for microarray analysis, that could activate minimally CD8+ cells) and/or methodological differences (differences of sensitivity between microarray and scRNA seq).

      Nevertheless, microarray data regarding CXCL8 expression are in good agreement with our in vitro experiments, showing an enhanced CXCL8 expression by CD8+ T cells purified from COPD lungs, in comparison with that of control subjects. In addition, the CXCL8 blocking antibody fully abrogates the increase of migration induced by secretion of COPD CD8+ T cells, to the same extent as the blocking of CXCR1/2 by reparixin. This suggests that this supplementary chemotaxis is mainly due to CXCL8 and not other CXCR1/2 binding CXCL chemokines, and correlates CXCL8 measurements to functional experiments. This precision has been now added in the text of the revised version.

      3) Inclusion of control/comparison cell types in co-culture studies would help establish that CD8 cells are more relevant for interactions with fibrocytes than for example CD4 cells.

      We have now performed co-cultures between fibrocytes and CD4+ T cells, with the same settings than for CD8+ T cells. The results from these experiments show that fibrocytes did not have any significant effect of CD4+ T cells death, regardless of their activation state (see new Figure 3-figure supplement 2A-C in the revised manuscript, and below). Fibrocytes were able to promote CD4+ T cells proliferation in the activated condition but not in the non-activated condition (see new Figure 3-figure supplement 2A-D in the revised manuscript). Altogether this indicates that although fibrocyte-mediated effect on proliferation is not specific to CD8+ T cells, the amplitude of the effect is much larger on CD8+ T cells than on CD4+ T cells.

      These new data have been added in the results section.

      4) In vitro analysis of cells from non-COPD patients would also help assess whether the circulating cells from COPD patients have a level of baseline activation which promotes the vicious cycle but may not exist in healthy cells.

      Regarding circulating cells, the present study relies on the COBRA cohort (COhort of BRonchial obstruction and Asthma), which includes only asthma and COPD patients, and therefore does not grant access to healthy subjects’ blood samples (Pretolani et al., 2017). Unfortunately, we have no other ongoing study with healthy subjects that would allow us to retrieve blood for research, and fibrocytes can only be grown from freshly drawn blood samples. We agree with the reviewer that it is a limitation of our study, which is now acknowledged at the end of the discussion section.  

      References

      Afroj, T., Mitsuhashi, A., Ogino, H., Saijo, A., Otsuka, K., Yoneda, H., Tobiume, M., Nguyen, N. T., Goto, H., Koyama, K., Sugimoto, M., Kondoh, O., Nokihara, H., & Nishioka, Y. (2021). Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes. The Journal of Immunology, 206(6), 1204‑1214. https://doi.org/10.4049/jimmunol.2000909

      Araki, K., Youngblood, B., & Ahmed, R. (2010). The role of mTOR in memory CD8+ T-cell differentiation. Immunological reviews, 235(1), 234‑243. https://doi.org/10.1111/j.0105-2896.2010.00898.x

      Bucala, R. J. (2022). Targeting fibrocytes in autoimmunity. Proceedings of the National Academy of Sciences, 119(5), e2121739119. https://doi.org/10.1073/pnas.2121739119

      Douglas, R. S., Kahaly, G. J., Patel, A., Sile, S., Thompson, E. H. Z., Perdok, R., Fleming, J. C., Fowler, B. T., Marcocci, C., Marinò, M., Antonelli, A., Dailey, R., Harris, G. J., Eckstein, A., Schiffman, J., Tang, R., Nelson, C., Salvi, M., Wester, S., … Smith, T. J. (2020). Teprotumumab for the Treatment of Active Thyroid Eye Disease. The New England Journal of Medicine, 382(4), 341‑352. https://doi.org/10.1056/NEJMoa1910434

      Dupin, I., Henrot, P., Maurat, E., Abohalaka, R., Chaigne, S., Hamrani, D. E., Eyraud, E., Prevel, R., Esteves, P., Campagnac, M., Dubreuil, M., Cardouat, G., Bouchet, C., Ousova, O., Dupuy, J.-W., Trian, T., Thumerel, M., Begueret, H., Girodet, P.-O., … Berger, P. (2023). CXCR4 blockade alleviates pulmonary and cardiac outcomes in early COPD (p. 2023.03.10.529743). bioRxiv. https://doi.org/10.1101/2023.03.10.529743

      Dupin, I., Thumerel, M., Maurat, E., Coste, F., Eyraud, E., Begueret, H., Trian, T., Montaudon, M., Marthan, R., Girodet, P.-O., & Berger, P. (2019). Fibrocyte accumulation in the airway walls of COPD patients. The European Respiratory Journal, 54(3), Article 3. https://doi.org/10.1183/13993003.02173-2018

      Fernando, R., Caldera, O., & Smith, T. J. (2021). Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy. Proceedings of the National Academy of Sciences, 118(52), e2114244118. https://doi.org/10.1073/pnas.2114244118

      Freeman, C. M., Han, M. K., Martinez, F. J., Murray, S., Liu, L. X., Chensue, S. W., Polak, T. J., Sonstein, J., Todt, J. C., Ames, T. M., Arenberg, D. A., Meldrum, C. A., Getty, C., McCloskey, L., & Curtis, J. L. (2010). Cytotoxic potential of lung CD8+ T cells increases with COPD severity and with in vitro stimulation by IL-18 or IL-15. Journal of immunology (Baltimore, Md. : 1950), 184(11), 6504‑6513. https://doi.org/10.4049/jimmunol.1000006

      Gillen, J. R., Zhao, Y., Harris, D. A., LaPar, D. J., Stone, M. L., Fernandez, L. G., Kron, I. L., & Lau, C. L. (2013). Rapamycin Blocks Fibrocyte Migration and Attenuates Bronchiolitis Obliterans in a Murine Model. The Annals of thoracic surgery, 95(5), 1768‑1775. https://doi.org/10.1016/j.athoracsur.2013.02.021

      Hombrink, P., Helbig, C., Backer, R. A., Piet, B., Oja, A. E., Stark, R., Brasser, G., Jongejan, A., Jonkers, R. E., Nota, B., Basak, O., Clevers, H. C., Moerland, P. D., Amsen, D., & van Lier, R. A. W. (2016). Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. Nature Immunology, 17(12), Article 12. https://doi.org/10.1038/ni.3589

      Maeno, T., Houghton, A. M., Quintero, P. A., Grumelli, S., Owen, C. A., & Shapiro, S. D. (2007). CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. Journal of Immunology (Baltimore, Md.: 1950), 178(12), 8090‑8096. https://doi.org/10.4049/jimmunol.178.12.8090

      Manjarres, D. C. G., Axell-House, D. B., Patel, D. C., Odackal, J., Yu, V., Burdick, M. D., & Mehrad, B. (2023). Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial. JCI Insight. https://doi.org/10.1172/jci.insight.166901

      Mehrad, B., Burdick, M. D., & Strieter, R. M. (2009). Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. The International Journal of Biochemistry & Cell Biology, 41(8‑9), 1708‑1718. https://doi.org/10.1016/j.biocel.2009.02.020

      Mitsuhashi, A., Goto, H., Saijo, A., Trung, V. T., Aono, Y., Ogino, H., Kuramoto, T., Tabata, S., Uehara, H., Izumi, K., Yoshida, M., Kobayashi, H., Takahashi, H., Gotoh, M., Kakiuchi, S., Hanibuchi, M., Yano, S., Yokomise, H., Sakiyama, S., & Nishioka, Y. (2015). Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab. Nature Communications, 6(1), Article 1. https://doi.org/10.1038/ncomms9792

      Mitsuhashi, A., Koyama, K., Ogino, H., Afroj, T., Nguyen, N. T., Yoneda, H., Otsuka, K., Sugimoto, M., Kondoh, O., Nokihara, H., Hanibuchi, M., Takizawa, H., Shinohara, T., & Nishioka, Y. (2023). Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade. Cell Reports, 112162. https://doi.org/10.1016/j.celrep.2023.112162

      Nemzek, J. A., Fry, C., & Moore, B. B. (2013). Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis. Shock (Augusta, Ga.), 40(2), 106‑114. https://doi.org/10.1097/SHK.0b013e31829c3c68

      O’Shaughnessy, T. C., Ansari, T. W., Barnes, N. C., & Jeffery, P. K. (1997). Inflammation in bronchial biopsies of subjects with chronic bronchitis : Inverse relationship of CD8+ T lymphocytes with FEV1. American Journal of Respiratory and Critical Care Medicine, 155(3), 852‑857. https://doi.org/10.1164/ajrccm.155.3.9117016

      Pilling, D., Fan, T., Huang, D., Kaul, B., & Gomer, R. H. (2009). Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PloS One, 4(10), e7475. https://doi.org/10.1371/journal.pone.0007475

      Pombo-Suarez, M., & Gomez-Reino, J. J. (2019). Abatacept for the treatment of rheumatoid arthritis. Expert Review of Clinical Immunology, 15(4), 319‑326. https://doi.org/10.1080/1744666X.2019.1579642

      Pretolani, M., Soussan, D., Poirier, I., Thabut, G., Aubier, M., COBRA Study Group, & COBRA cohort Study Group. (2017). Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma. The European Respiratory Journal, 50(2), 1700019. https://doi.org/10.1183/13993003.00019-2017

      Roos-Engstrand, E., Ekstrand-Hammarström, B., Pourazar, J., Behndig, A. F., Bucht, A., & Blomberg, A. (2009). Influence of smoking cessation on airway T lymphocyte subsets in COPD. COPD, 6(2), 112‑120. https://doi.org/10.1080/15412550902755358

      Rozelle, A. L., & Genovese, M. C. (2007). Efficacy results from pivotal clinical trials with abatacept. Clinical and Experimental Rheumatology, 25(5 Suppl 46), S30-34.

      Sauler, M., McDonough, J. E., Adams, T. S., Kothapalli, N., Barnthaler, T., Werder, R. B., Schupp, J. C., Nouws, J., Robertson, M. J., Coarfa, C., Yang, T., Chioccioli, M., Omote, N., Cosme, C., Poli, S., Ayaub, E. A., Chu, S. G., Jensen, K. H., Gomez, J. L., … Rosas, I. O. (2022). Characterization of the COPD alveolar niche using single-cell RNA sequencing. Nature Communications, 13(1), Article 1. https://doi.org/10.1038/s41467-022-28062-9

      Siena, L., Gjomarkaj, M., Elliot, J., Pace, E., Bruno, A., Baraldo, S., Saetta, M., Bonsignore, M. R., & James, A. (2011). Reduced apoptosis of CD8+ T-lymphocytes in the airways of smokers with mild/moderate COPD. Respiratory Medicine, 105(10), 1491‑1500. https://doi.org/10.1016/j.rmed.2011.04.014

      Smith, T. J., Kahaly, G. J., Ezra, D. G., Fleming, J. C., Dailey, R. A., Tang, R. A., Harris, G. J., Antonelli, A., Salvi, M., Goldberg, R. A., Gigantelli, J. W., Couch, S. M., Shriver, E. M., Hayek, B. R., Hink, E. M., Woodward, R. M., Gabriel, K., Magni, G., & Douglas, R. S. (2017). Teprotumumab for Thyroid-Associated Ophthalmopathy. The New England Journal of Medicine, 376(18), 1748‑1761. https://doi.org/10.1056/NEJMoa1614949

      Vincenti, F., Rostaing, L., Grinyo, J., Rice, K., Steinberg, S., Gaite, L., Moal, M.-C., Mondragon-Ramirez, G. A., Kothari, J., Polinsky, M. S., Meier-Kriesche, H.-U., Munier, S., & Larsen, C. P. (2016). Belatacept and Long-Term Outcomes in Kidney Transplantation. The New England Journal of Medicine, 374(4), 333‑343. https://doi.org/10.1056/NEJMoa1506027

      Wang, X., Zhang, D., Higham, A., Wolosianka, S., Gai, X., Zhou, L., Petersen, H., Pinto-Plata, V., Divo, M., Silverman, E. K., Celli, B., Singh, D., Sun, Y., & Owen, C. A. (2020). ADAM15 expression is increased in lung CD8+ T cells, macrophages, and bronchial epithelial cells in patients with COPD and is inversely related to airflow obstruction. Respiratory Research, 21(1), 188. https://doi.org/10.1186/s12931-020-01446-5

      Zenke, S., Palm, M. M., Braun, J., Gavrilov, A., Meiser, P., Böttcher, J. P., Beyersdorf, N., Ehl, S., Gerard, A., Lämmermann, T., Schumacher, T. N., Beltman, J. B., & Rohr, J. C. (2020). Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics. Immunity, 52(2), 313-327.e7. https://doi.org/10.1016/j.immuni.2020.01.018

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1:

      Comment 0: Summary: This work presents an Interpretable protein-DNA Energy Associative (IDEA) model for predicting binding sites and affinities of DNA-binding proteins. Experimental results demonstrate that such an energy model can predict DNA recognition sites and their binding strengths across various protein families and can capture the absolute protein-DNA binding free energies.

      We appreciate the reviewer’s careful assessment of the paper, and we thank the reviewer for the insightful suggestions and comments.

      Comment 1: Strengths: (1) The IDEA model integrates both structural and sequence information, although such an integration is not completely original. (2) The IDEA predictions seem to have agreement with experimental data such as ChIP-seq measurements.

      We appreciate the reviewer’s positive comments on the strength of the paper.

      Comment 2: Weaknesses: (1) The authors claim that the binding free energy calculated by IDEA, trained using one MAX-DNA complex, correlates well with experimentally measured MAX-DNA binding free energy (Figure 2) based on the reported Pearson Correlation of 0.67. However, the scatter plot in Figure 2A exhibits distinct clustering of the points and thus the linear fit to the data (red line) may not be ideal. As such. the use of the Pearson correlation coefficient that measures linear correlation between two sets of data may not be appropriate and may provide misleading results for non-linear relationships.

      We thank the reviewer for the insightful comments and agree that a linear fit between our predictions and the experimental data may not be the best measure of performance. The primary utility of the IDEA model is to predict high-affinity DNA-binding sequences for a given DNA-binding protein by assessing the relative binding affinities across different DNA sequences. In this regard, the ranked order of predicted sequence binding affinities serves as a better metric for evaluating the success of this model. To evaluate this, we calculated both Spearman’s rank correlation coefficient, which does not rely on linear correlation, and the Pearson correlation coefficient between our predictions and the experimental results. As shown in Figure 2, our computation shows a Spearman’s rank correlation coefficient of 0.65 for the MAX-based predictions using one MAX-DNA complex (PDB ID: 1HLO), supporting the model’s capability to effectively distinguish strong from weak binders.

      Although our model generally captures the relative binding affinities across different DNA sequences, its predictive accuracy diminishes for low-affinity sequences (Figure 2).

      This could be due to two limitations of the current modeling framework: (1) The model is residue-based and estimates binding free energy as the additive sum of contributions from individual contacting amino-acid-nucleotide pairs. This assumption does not account for cooperative effects caused by simultaneous changes at multiple nucleotide positions. One potential direction to further improve the model would be to use a finergrained representation by incorporating more atom types within contacting residues, and to use a many-body potential to better capture cooperative effects from multiple mutations. (2) The model assumes that the target DNA adopts the same binding interface as in the reference crystal structure. However, sequence-dependent DNA shape has been shown to be important in determining protein-DNA binding affinity [1]. To address this limitation, a future direction is to use deep-learning-based methods to incorporate predicted DNA shape or protein-DNA complex structures based on their sequences [2, 3] into our model prediction.

      To fully evaluate the predictive power of IDEA, we have included Spearman’s rank correlation coefficient for every correlation plot in this manuscript and have updated the relevant texts. Across all our analyses, the Spearman’s rank correlation coefficients reveal similar predictive performance as the Pearson correlation coefficients. Additionally, we have included in our discussion the current limitations of our model and potential directions for future improvement.

      We have edited our Discussion Section to include a discussion on the limitations of the current model. Specifically, the added texts are:

      “Although IDEA has proved successful in many examples, it can be improved in several aspects. The model currently assumes the training and testing sequences share the same protein-DNA structure. While double-stranded DNA is generally rigid, recent studies have shown that sequence-dependent DNA shape contributes to their binding specificity [1, 2, 4]. To improve predictive accuracy, one could incorporate predicted DNA shapes or structures into the IDEA training protocol. In addition, the model is residue-based and evaluates the binding free energy as the additive sum of contributions from individual amino-acid-nucleotide contacts. This assumption does not account for cooperative effects that may arise from multiple nucleotide changes. A potential refinement could utilize a finer-grained model that includes more atom types within contacting residues and employs a many-body potential to account for such cooperative effects.”

      Comment 3: (2) In the same vein, the linear Pearson Correlation analysis performed in Figure 5A and the conclusion drawn may be misleading.

      We thank the reviewer for the insightful comments. As noted in our response to the previous comment, we have added Spearman’s rank correlation coefficient in addition to the Pearson correlation coefficient to all correlation plots, including Figure 5A.

      Comment 4: (3) The authors included the sequences of the protein and DNA residues that form close contacts in the structure in the training dataset, whereas a series of synthetic decoy sequences were generated by randomizing the contacting residues in both the protein and DNA sequences. In particular, synthetic decoy binders were generated by randomizing either the DNA (1000 sequences) or protein sequences (10,000 sequences) from the strong binders. However, the justification for such randomization and how it might impact the model’s generalizability and transferability remain unclear.

      We thank the reviewer for the insightful comments. The number of randomizing sequences was chosen to strike a balance between sufficient sequence coverage and computational feasibility. Because proteins have more types of amino acids than four nucleotides in DNA, we utilized more protein decoy sequences than DNA decoys. To examine the robustness of our choice against different number of decoy sequences, we repeated the transferability analysis within the bHLH superfamily (Figure 3A) and the generalizability analysis across 12 protein families (Figure 2E) using two additional decoy sequence combinations: (1) 1000 DNA sequences and 1000 protein sequences; (2) 100 DNA sequences and 1000 protein sequences. As shown in Figure S15, we achieved similar results to those reported using the original decoy set, demonstrating the robustness of our model prediction against the variations in the number of decoys. We have included this figure as Figure S15.

      Comment 5: (4) The authors performed Receiver Operating Characteristic (ROC) analysis and reported the Area Under the Curve (AUC) scores in order to quantitate the successful identification of the strong binders by IDEA. It would be beneficial to analyze the precision-recall (PR) curve and report the PRAUC metric which could be more robust.

      We agree with the reviewer that more robust statistical metrics should be used to evaluate our model’s performance. We have included the PRAUC score as an additional evaluation metric of the model’s performance. Due to a significant imbalance in the number of strong and weak binders from the experimental data [5], where the experimentally identified strong binders are far fewer than the weak binders, we reweighted the sample to achieve a balanced evaluation [6], using 0.5 as the baseline for randomized prediction. As shown in Figure S5, IDEA achieves successful predictions in 18 out of 22 cases, demonstrating its predictive accuracy.

      The updated PRAUC result has been included as Figure S5 in the manuscript. We have also included the detailed precision-recall curves for each case in Figure S4.

      In addition, we have provided PRAUC scores for comparing the performance of IDEA with other models, and have summarized these results in Table S2.

      Reviewer #2:

      Comment 0: Summary: Zhang et al. present a methodology to model protein-DNA interactions via learning an optimizable energy model, taking into account a representative bound structure for the system and binding data. The methodology is sound and interesting. They apply this model for predicting binding affinity data and binding sites in vivo. However, the manuscript lacks discussion of/comparison with state-of-the-art and evidence of broad applicability. The interpretability aspect is weak, yet over-emphasized.

      We appreciate the reviewer’s excellent summary of the paper, and we thank the reviewer for the insightful suggestions and comments.

      Comment 1: Strengths: The manuscript is well organized with good visualizations and is easy to follow. The methodology is discussed in detail. The IDEA energy model seems like an interesting way to study a protein-DNA system in the context of a given structure and binding data. The authors show that an IDEA model trained on one system can be transferred to other structurally similar systems. The authors show good performance in discriminating between binding-vs-decoy sequences for various systems, and binding affinity prediction. The authors also show evidence of the ability to predict genome-wide binding sites.

      We appreciate the reviewer’s strong assessment of the strengths of this paper. We have further refined our Methods Section to ensure all modeling details are clearly presented.

      Comment 2: Weaknesses: An energy-based model that needs to be optimized for specific systems is inherently an uncomfortable idea. Is this kind of energy model superior to something like Rosetta-based energy models, which are generally applicable? Or is it superior to family-specific knowledge-based models? It is not clear.

      We thank the reviewer for the insightful comments. The protein-DNA energy model facilitates the calculation of protein-DNA binding free energy based on protein-DNA structures and sequences. Because this model is optimized using the structure-sequence relationship of given protein-DNA complexes, it features specificity based on the conserved structural interface characteristic of each protein family. Because of that, its predictive accuracy depends on the degree of protein-DNA interface similarity between the training and target protein-DNA pairs, and is distinct from a general protein-DNA energy model, such as a Rosetta-based energy model. The model has some connections to the familyspecific energy model. As shown in Author response image 1, systems belonging to the same protein superfamily (MAX and PHO4) exhibit similar patterns in their learned energy models, in contrast to those from a different superfamily (PDX1).

      Author response image 1:

      Comparison of learned energy models for different protein-DNA complexes: MAX (A), PHO4 (B), and PDX1 (C). MAX and PHO4 are members of the Helixloop-helix (HLH) CATH protein superfamily (4.10.280.100), while PDX1 belongs to another Homeodomain-like CATH protein superfamily (1.10.10.60).

      To compare our approach with both general and family-specific knowledge-based energy models, we conducted two studies. First, we incorporated a knowledge-based generic protein-DNA energy model (DBD-Hunter) learned from the protein-DNA database, reported by Skoinick and coworkers [7], into our prediction protocol. This model assigns interaction energies to different functional groups within each DNA nucleotide (e.g., phosphate (PP), sugar (SU), pyrimidine (PY), and imidazole (IM) groups). For our comparison, we averaged the energy contributions of these groups within each nucleotide and replaced the IDEA-learned energy model with this generic one to test its ability to differentiate strong binders from weak binders in the HT-SELEX dataset [5]. As shown in Figure S6, the IDEA model generally achieves better performance than the generic energy model.

      Additionally, we compared IDEA with rCLAMPS, a family-specific energy model developed to predict protein-DNA binding specificity in the C2H2 and homeodomain families.

      As shown in Table S1 and Table S2, IDEA also shows better performance than rCLAMPS in most cases across the C2H2 and homeodomain families, demonstrating that it has better predictive accuracy than both state-of-the-art family-specific and generic knowledgebased models.

      We have included relevant texts in Appendix Section Comparison of IDEA predictive performance Using HT-SELEX data to clarify this point. The added texts are:

      In addition, we compared the performance of IDEA with both general and family-specific knowledge-based energy models. First, we incorporated a knowledgebased generic protein-DNA energy model (DBD-Hunter) learned from the protein-DNA database, reported by Skoinick and coworkers [7], into our prediction protocol. This model assigns interaction energies to different functional groups within each DNA nucleotide, including phosphate (PP), sugar (SU), pyrimidine (PY), and imidazole (IM) groups. For our comparison, we averaged the energy contributions of these groups within each nucleotide and replaced the IDEA-learned energy model with the DBD-Hunter model to assess its ability to differentiate strong binders from weak binders in the HTSELEX dataset [5]. Additionally, we compared IDEA with rCLAMPS, a familyspecific energy model developed to predict protein-DNA binding specificity in the C2H2 and homeodomain families. rCLAMPS learns a position-dependent amino-acid-nucleotide interaction energy model. To incorporate this model into the binding free energy calculation, we averaged the energy contributions across all occurrences of each amino-acid-nucleotide pair, which resulted in a 20-by-4 residue-type-specific energy matrix. This matrix is structurally analogous to the IDEA-trained energy model and can be directly integrated into the binding free energy calculations. As shown in Figure S6, Table S1, and Table S2, the IDEA model generally outperforms DBD-Hunter and rCLAMPS, demonstrating that it can achieve better predictive accuracy than both generic and family-specific knowledge-based models.

      Comment 3: Prediction of binding affinity is a well-studied domain and many competitors exist, some of which are well-used. However, no quantitative comparison to such methods is presented. To understand the scope of the presented method, IDEA, the authors should discuss/compare with such methods (e.g. PMID 35606422).

      We thank the reviewer for the insightful comments. As detailed in our response to Comment 5, we previously misused the term “binding specificity”, and would like to clarify that our model is designed to predict protein-DNA binding affinity. To compare the performance of IDEA with state-of-the-art protein-DNA predictive models, we examined the predictive accuracies of two additional popular computational models: ProBound [8] and DeepBind [9]. ProBound has been shown to have a better performance than several earlier predictive protein-DNA models, including JASPAR 2018 [11], HOCOMOCO [12], Jolma et al. [13], and DeepSELEX [14]. To benchmark these models’ performance, we examine each method’s capability to identify strong binders with the HT-SELEX datasets covering 22 proteins from 12 protein families [5]. As suggested by Reviewer 1, we also calculated the PRAUC score, reweighted to account for data imbalance [6], as a complementary metric for evaluating the model performance.

      As shown in Figure S6, Table S1, and Table S2, IDEA ranked second among the three predictive methods. It is important to note that both ProBound and DeepBind were trained on a curated version of the HT-SELEX data [13], which overlaps with the testing data [5]. Compared with them, IDEA was trained only on the given structural and sequence information from a single protein-DNA complex, thus independent of the testing data. In order to assess how IDEA performs when incorporating knowledge from HT-SELEX data, we augmented the training by randomly including half of the HT-SELEX data (see the Methods Section Enhanced Modeling Prediction with SELEX Data). The augmented IDEA model achieved the best performance among all the models. Overall, IDEA can be used to predict protein-DNA affinities in the absence of known binding sequence data, thereby filling a critical gap when such experimental datasets are unavailable.

      Additionally, we have conducted a 10-fold cross-validation using the same HT-SELEX data [5] and found that IDEA outperformed a recent regression model that considers the shape of DNA with different sequences [5].

      We have revised our text to include the comparison between IDEA and other predictive models. Specifically, we revised the text in Section: IDEA Generalizes across Various Protein Families.

      The revised text reads:

      “To examine IDEA’s predictive accuracy across different DNA-binding protein families, we applied it to calculate protein-DNA binding affinities using a comprehensive HT-SELEX dataset [5]. We focused on evaluating the capability of IDEA to distinguish strong binders from weak binders for each protein with an experimentally determined structure. We calculated the probability density distribution of the top and bottom binders identified in the SELEX experiment. A well-separated distribution indicates the successful identification of strong binders by IDEA (Figure 2D and S4). Receiver Operating Characteristic (ROC) analysis was performed to calculate the Area Under the Curve (AUC) and the precision-recall curve (PRAUC) scores for these predictions. Further details are provided in the Methods Section Evaluation of IDEA Prediction Using HT-SELEX Data. Our analysis shows that IDEA successfully differentiates strong from weak binders for 80% of the 22 proteins across 12 protein families, achieving AUC and balanced PRAUC scores greater than 0.5 (Figure 2D and S5). To benchmark IDEA’s performance against other leading methods, we compared its predictions with several popular models, including the sequence-based predictive models ProBound [8] and DeepBind [9], the familybased energy model rCLAMPS [10], and the knowledge-based energy model DBD-Hunter [7]. IDEA demonstrates performance comparable to these stateof-the-art approaches, and incorporating sequence features further improves its prediction accuracy (Figure S6, Table S1, and Table S2). We also performed 10-fold cross-validation on the binding affinities of protein–DNA pairs in this dataset and found that IDEA outperforms a recent regression model that considers the shape of DNA with different sequences [5] (Figure S7). Details are provided in Section: Comparison of IDEA predictive performance Using HT-SELEX data.”

      We also added one section Comparison of IDEA predictive performance Using HT-SELEX data in the Appendix to fully explain the comparison between IDEA and other popular models. The added texts are:

      “To benchmark the performance of IDEA against state-of-the-art protein-DNA predictive models, we evaluated its ability to recognize strong binders with the HT-SELEX datasets across 22 proteins from 12 families [5]. Specifically, we compare IDEA with two widely used sequence-based models: ProBound [8] and DeepBind [9]. ProBound has demonstrated superior performance over many other predictive protein-DNA models, including JASPAR 2018 [11], HOCOMOCO [12], Jolma et al. [13], and DeepSELEX [14]. To use ProBound, we retrieved the trained binding model for each protein from motifcentral.org and used the GitHub implementation of ProBoundTools to infer the binding scores between protein and target DNA sequences. Except for POU3F1, binding models are available for all proteins. Therefore, we excluded POU3F1 and evaluated the protein-DNA binding affinities for the remaining 21 proteins. To use DeepBind, sequence-specific binding affinities were predicted directly with its web server. The Area Under the Curve (AUC) and the Precision-Recall AUC (PRAUC) scores were used as metrics for comparison. An AUC score of 1.0 indicates a perfect separation between the strong- and weak-binder distributions, while an AUC score of 0.5 indicates no separation. Because there is a significant imbalance in the number of strong and weak binders from the experimental data [5], where the strong binders are far fewer than the weak binders, we reweighted the samples to achieve a balanced evaluation, using 0.5 as the baseline for randomized prediction [6]. As summarized in Figure S6, Table S1, and Table S2, IDEA ranked second among the three predictive models. In order to assess the performance of IDEA when augmented with additional protein-DNA binding data, we augmented IDEA using randomly selected half of the HT-SELEX data (see the Methods Section Enhanced Modeling Prediction with SELEX Data). The augmented IDEA model achieved the best performance among all the models.”

      “We also performed 10-fold cross-validation using the same HT-SELEX datasets, following the protocol described in the Methods Section Enhanced Modeling Prediction with SELEX Data. For each protein, we divided the entire dataset into 10 equal, randomly assigned folds. In each iteration, we used randomly selected 9 of the 10 folds as the training dataset and the remaining fold as the testing dataset. This process was repeated 10 times so that each fold served as the test set once. We then reported the average R2 scores across these iterations to evaluate IDEA’s predictive performance. Our results are compared with the 1mer and 1mer+shape methods from [5], the latest regression model that considers the shape of DNA with different sequences (Figure S7). This comparative analysis shows IDEA achieved higher predictive accuracy than the state-of-the-art sequence-based protein-DNA binding predictors for proteinDNA complexes that have available experimentally resolved structures.”

      “Overall, these results demonstrate that IDEA can be used to predict the proteinDNA pairs in the absence of known binding sequence data, thus filling an important gap in protein-DNA predictions when experimental binding sequence data are unavailable.”

      Comment 4: The term “interpretable” has been used lavishly in the manuscript while providing little evidence on the matter. The only evidence shown is the family-specific residue-nucleotide interaction/energy matrix and speculations on how these values are biologically sensible. Recent works already present more biophysical, fine-grained, and sometimes family-independent interpretability (e.g. PMID 39103447, 36656856, 38352411, etc.). The authors should put into context the scope of the interpretability of IDEA among such works.

      We thank the reviewer for the insightful comment and agree that “interpretability” should be discussed in a relevant context. In our work, interpretability refers to the familyspecific amino-acid-nucleotide interaction energies identified from the model training, which reveal interaction preferences within protein-DNA binding interfaces. As detailed in our response to Comment 6, we performed principal component analysis (PCA) on the learned energy models and observed clustering of learned energy models corresponding to protein families. Therefore, the IDEA-learned energy models can be used as a signature to capture the energetic preferences of amino-acid-nucleotide interactions within a given protein family. This preference can be used to infer preferred sequence binding motifs, similar to those identified by other computational tools [10, 4, 15, 16].

      We have revised the text to clarify the “interpretability” as the family-specific aminoacid-nucleotide interactions that govern sequence-dependent protein-DNA binding, and to discuss IDEA’s interoperability within the context of recent works, including those suggested by the reviewers.

      We have revised the text in Introduction. The new text reads:

      “Here, we introduce the Interpretable protein-DNA Energy Associative (IDEA) model, a predictive model that learns protein-DNA physicochemical interactions by fusing available biophysical structures and their associated sequences into an optimized energy model (Figure 1). We show that the model can be used to accurately predict the sequence-specific DNA binding affinities of DNA-binding proteins and is transferrable across the same protein superfamily. Moreover, the model can be enhanced by incorporating experimental binding data and can be generalized to enable base-pair resolution predictions of genomic DNA-binding sites. Notably, IDEA learns a family-specific interaction matrix that quantifies energetic interactions between each amino acid and nucleotide, allowing for a direct interpretation of the “molecular grammar” governing sequence-specific protein-DNA binding affinities. This interpretable energy model is further integrated into a simulation framework, facilitating mechanistic studies of various biomolecular functions involving protein-DNA dynamics.”

      We have revised the text in Results. The new text reads:

      “IDEA is a coarse-grained biophysical model at the residue resolution for investigating protein-DNA binding interactions (Figure 1). It integrates both structures and corresponding sequences of known protein-DNA complexes to learn an interpretable energy model based on the interacting amino acids and nucleotides at the protein-DNA binding interface. The model is trained using available protein-DNA complexes curated from existing databases [17, 18].

      Unlike existing deep-learning-based protein-DNA binding prediction models, IDEA aims to learn a physicochemical-based energy model that quantitatively characterizes sequence-specific interactions between amino acids and nucleotides, thereby interpreting the “molecular grammar” driving the binding energetics of protein-DNA interactions. The optimized energy model can be used to predict the binding affinity of any given protein-DNA pair based on its structures and sequences. Additionally, it enables the prediction of genomic DNA binding sites by a given protein, such as a transcription factor. Finally, the learned energy model can be incorporated into a simulation framework to study the dynamics of DNA-binding processes, revealing mechanistic insights into various DNA-templated processes. Further details of the optimization protocol are provided in Methods Section Energy Model Optimization.”

      The revised text in Section: Discussion now reads:

      “Another highlight of IDEA is its ability to present an interpretable, familyspecific amino acid-nucleotide interaction energy model for given proteinDNA complexes. The optimized IDEA energy model can not only predict sequence-specific binding affinities of protein-DNA pairs but also provide a residue-specific interaction matrix that dictates the preferences of amino acidnucleotide interactions within specific protein families (Figure S11). This interpretable energy matrix would facilitate the discovery of sequence binding motifs for target DNA-binding proteins, complementing both sequencebased [24, 16, 25] and structure-based approaches [10, 26, 4, 15]. Additionally, we integrated this physicochemical-based energy model into a simulation framework, thereby improving the characterization of protein-DNA binding dynamics. IDEA-based simulation enables the investigation into dynamic interactions between various proteins and DNA, facilitating molecular-level understanding of the physical mechanisms underlying many DNA-binding processes, such as transcription, epigenetic regulations, and their modulation by sequence variations, such as single-nucleotide polymorphisms (SNPs) [22, 23].”

      Comment 5: The manuscript disregards subtle yet important differences in commonly used terminology in the field. For example, the authors use the term ”specificity” and ”affinity” almost interchangeably (for example, the caption for Figure 3A uses ”specificity” although the Methods text describes the prediction as about ”affinity”). If the authors are looking to predict specificity, IDEA needs to be put in the context of the corresponding state-of-the-art (PMID 36123148, 39103447, 38867914, 36124796, etc).

      We really appreciate the reviewer for pointing out the conflation of “specificity” and “affinity” in our manuscript. To clarify, the primary function of IDEA is to predict the binding affinities of protein-DNA pairs in a sequence-specific manner. We have revised the text to clarify the distinction between affinity and specificity and acknowledge prior works, including those provided by the reviewers, that focus on predicting protein-DNA binding specificity.

      We have revised the Section title IDEA Accurately Predicts Protein-DNA Binding Specificity to IDEA Accurately Predicts Sequence-Specific Protein-DNA Binding Affinity; and ResidueLevel Protein-DNA Energy Model for Predicting Protein-DNA Recognition Specificities to Predictive Protein-DNA Energy Model at Residue Resolution.

      We have revised the text in Introduction. The revised text reads:

      “Computational methods complement experimental efforts by providing the initial filter for assessing sequence-specific protein-DNA binding affinity. Numerous methods have emerged to enable predictions of binding sites and affinities of DNA-binding proteins [27, 9, 1, 5, 28, 29, 30, 31, 8]. These methods often utilized machine-learning-based training to extract sequence preference information from DNA or protein by utilizing experimental high-throughput (HT) assays [27, 9, 1, 5, 28, 8], which rely on the availability and quality of experimental binding assays. Additionally, many approaches employ deep neural networks [29, 30, 31], which could obscure the interpretation of interaction patterns governing protein-DNA binding specificities. Understanding these patterns, however, is crucial for elucidating the molecular mechanisms underlying various DNA-recognition processes, such as those seen in TFs [32].”

      We have revised the text in Section: IDEA Demonstrates Transferability across Proteins in the Same CATH Superfamily.

      The revised text reads:

      “Since IDEA relies on the sequence-structure relationship of given protein-DNA complexes to reach predictive accuracy, we inquired whether the trained energy model from one protein-DNA complex could be generalized to predict the sequence-specific binding affinities of other complexes. To test this, we assessed the transferability of IDEA predictions across all 11 structurally available protein-DNA complexes within the MAX TF-associated CATH superfamily (CATH ID: 4.10.280.10, Helix-loop-helix DNA-binding domain). We trained IDEA based on each of these 11 complexes and then used the trained model to predict the MAX-based MITOMI binding affinity. Our results show that IDEA generally makes correct predictions of the binding affinity when trained on proteins that are homologous to MAX, with Pearson and Spearman Correlation coefficients larger than 0.5 (Figure 3A and Figure S10).”

      We have revised the caption of Figure 3: The revised text reads:

      “IDEA prediction shows transferability within the same CATH superfamily. (A) The predicted MAX binding affinity, trained on other protein-DNA complexes within the same protein CATH superfamily, correlates well with experimental measurement. The proteins are ordered by their probability of being homologous to the MAX protein, determined using HHpred [33]. Training with a homologous protein (determined as a hit by HHpred) usually leads to better predictive performance (Pearson Correlation coefficient > 0.5) compared to non-homologous proteins. (B) Structural alignment between 1HLO (white) and 1A0A (blue), two protein-DNA complexes within the same CATH Helix-loop-helix superfamily. The alignment was performed based on the Ebox region of the DNA [34]. (C) The optimized energy model for 1A0A, a protein-DNA complex structure of the transcription factor PHO4 and DNA, with 33.41% probability of being homologous to the MAX protein. The optimized energy model is presented in reduced units, as explained in the Methods Section: Training Protocol.”

      We have revised the text in Section Discussion: The revised text now reads:

      “The protein-DNA interaction landscape has evolved to facilitate precise targeting of proteins towards their functional binding sites, which underlie essential processes in controlling gene expression. These interaction specifics are determined by physicochemical interactions between amino acids and nucleotides. By integrating sequences and structural data from available proteinDNA complexes into an interaction matrix, we introduce IDEA, a data-driven method that optimizes a system-specific energy model. This model enables high-throughput in silico predictions of protein-DNA binding specificities and can be scaled up to predict genomic binding sites of DNA-binding proteins, such as TFs. IDEA achieves accurate de novo predictions using only proteinDNA complex structures and their associated sequences, but its accuracy can be further enhanced by incorporating available experimental data from other binding assay measurements, such as the SELEX data [35, 36, 37], achieving accuracy comparable or better than state-of-the-art methods (Figures S2 and S7, Table S1 and S2). Despite significant progress in genome-wide sequencing techniques [38, 39, 40, 41], determining sequence-specific binding affinities of DNA-binding biomolecules remains time-consuming and expensive. Therefore, IDEA presents a cost-effective alternative for generating the initial predictions before pursuing further experimental refinement.”

      We have revised the text in Discussion to clarify that the acquired binding affinities of target DNA sequences can be used to help existing models to infer specific DNA binding motifs.

      The revised text now reads:

      Another highlight of IDEA is its ability to present an interpretable, familyspecific amino acid-nucleotide interaction energy model for given proteinDNA complexes. The optimized IDEA energy model can not only predict sequence-specific binding affinities of protein-DNA pairs but also provide a residue-specific interaction matrix that dictates the preferences of amino acidnucleotide interactions within specific protein families (Figure S11). This interpretable energy matrix would facilitate the discovery of sequence binding motifs for target DNA-binding proteins, complementing both sequencebased [24, 16, 25] and structure-based approaches [10, 26, 4, 15]. Additionally, we integrated this physicochemical-based energy model into a simulation framework, thereby improving the characterization of protein-DNA binding dynamics. IDEA-based simulation enables the investigation into dynamic interactions between various proteins and DNA, facilitating molecular-level understanding of the physical mechanisms underlying many DNA-binding processes, such as transcription, epigenetic regulations, and their modulation by sequence variations, such as single-nucleotide polymorphisms (SNPs) [22, 23].

      Comment 6: It is not clear how much the learned energy model is dependent on the structural model used for a specific system/family. It would be interesting to see the differences in learned model based on different representative PDB structures used. Similarly, the supplementary figures show a lack of discriminative power for proteins like PDX1 (homeodomain family), POU, etc. Can the authors shed some light on why such different performances?

      We thank the reviewer for the insightful comments and agree that the trained energy model should be presented in the context of protein families. To further analyze the dependence of the energy model on protein family, we visualized the trained energy models for 24 proteins, including all proteins from the HT-SELEX dataset as well as PHO4 (PDB ID: 1A0A) and CTCF (PDB ID: 8SSQ), spanning 12 distinct protein families. To quantitatively assess similarities and differences among these energy models, we flattened each normalized energy model into an 80-dimensional vector and performed principal component analysis (PCA). As shown in Author response image 1 and Figure S11, energy models optimized from the same protein family fall within the same cluster, while those from different protein families exhibit distinct patterns. Moreover, the relative distance between energy models in PCA space reflects the degree of transferability. For example, PHO4 (PDB ID: 1A0A) is positioned close to MAX (PDB ID: 1HLO), whereas USF1 (PDB ID: 1AN4) and TCF4 (PDB ID: 6OD3) are farther away. This is consistent with the results shown in Figure 3A, where the energy model trained from PHO4 has better transferability than those from the other two systems.

      We also greatly appreciate the reviewer’s suggestion to examine cases where IDEA failed to demonstrate strong discriminative power. When evaluating the model’s ability to distinguish between strong and weak binders, we used the available experimental structure most similar to the protein employed in the HT-SELEX experiments. In some instances, only the structure of the same protein from a different organism is available. For example, the HT-SELEX data for PDX1-DNA used the human PDX1 protein, but no human PDX1–DNA complex structure is available. Therefore, we used the mouse PDX1–DNA complex (PDB ID: 2H1K) for model training. The differences between species may limit the predictive accuracy of the model. A similar limitation applies to POU3F1, where an available mouse complex (PDB ID: 4Y60) was used to predict human protein–DNA interactions. Notably, DeepBind [9], a sequence-based prediction tool, also failed to distinguish strong from weak binders when using the mouse POU3F1 protein (AUC score: 0.457), but this was corrected with the human POU3F1 protein (AUC score: 0.956).

      We also examined the remaining cases where IDEA did not show a clear distinction between strong and weak binders: USF1, Egr1, and PROX1. For PROX1, we initially used the structure of a protein-DNA complex (PDB ID: 4Y60) in training. However, upon closer inspection, we discovered that this structure does not include the PROX1 protein, but SOX-18, a different transcription factor. This explains the inaccurate prediction made by IDEA. Since no experimental PROX1-DNA complex structure is currently available, we have removed this case from our HT-SELEX evaluation.

      IDEA also fails to fully resolve the binding preference of USF1. A closer examination of the HT-SELEX data reveals a lack of distinction among the sequences, as most sequences, including those with the lowest M-word (binding affinity) scores, contain the DNA-binding E-box sequence CACGTG. Therefore, USF1 represents a challenging example where the experimental data only consists of strong binders with limited variations in binding affinity, which likely results from differences in flanking sequences of the E-box motif.

      Egr1 stands as a peculiar example. Whereas IDEA does not effectively distinguish between the strong and weak binders in the current HT-SELEX dataset, its predictions are consistent with other experimental datasets, including binding affinities measured by kMITOMI [42] (Figure S8A, B), preferred binding sequences from protein-binding microarray, an earlier HT-SELEX experiment, and bacterial one-hybrid data [43]. Therefore, further investigation of the current HT-SELEX data is needed to reconcile these differences.

      We have included additional text in Section: IDEA Demonstrates Transferability across Proteins in the Same CATH Superfamily to discuss the PCA analysis and the dependence of the model’s transferability on the similarity among the learned energy models.

      The revised text now reads:

      “The transferability of IDEA within the same CATH superfamily can be understood from the similarities in protein-DNA binding interfaces, which determine similar learned energy models. For example, the PHO4 protein (PDB I”D: 1A0A) shares a highly similar DNA-binding interface with the MAX protein (PDB ID: 1HLO) (Figure 3B), despite sharing only a 33.41% probability of being homologous. Consequently, the energy model derived from the PHO4DNA complex (Figure 3C) exhibits a similar amino-acid-nucleotide interactive pattern as that learned from the MAX-DNA complex (Figure 2B). To further evaluate the similarity between the learned energy models and their connection to protein families, we performed principal component analysis (PCA) on the normalized energy models across 24 proteins from 12 protein families [5]. Our analysis (Figure S11) reveals that most of the energy models from the same protein family fall within the same cluster, while those from different protein families exhibit distinct patterns. Moreover, the relative distance between energy models in PCA space reflects the degree of transferability between them. For example, PHO4 (PDB ID: 1A0A) is positioned close to MAX (PDB ID: 1HLO), whereas USF1 (PDB ID: 1AN4) and TCF4 (PDB ID: 6OD3) are farther away. This is consistent with the results in Figure 3A, where the energy model trained on PHO4 has better transferability than those trained on USF1 or TCF4.”

      We have also added an Appendix section titled Analysis of examples where IDEA fails to recognize strong DNA binders to discuss the examples in which IDEA did not perform well:

      “We examine IDEA’s capability in identifying strong binders from the HT-SELEX dataset across 12 protein families [5]. The model successfully predicts 18 out of 22 protein-DNA systems, but the performance is reduced in 4 cases. Closer investigations revealed the source of these limitations. In some instances, only the protein from a different organism is available. For example, the PDX1 HT-SELEX data utilized the human PDX1 protein, but no human PDX1–DNA complex structure is available. Therefore, the mouse PDX1–DNA complex structure (PDB ID: 2H1K) was used for model training. Differences between model organisms may reduce predictive accuracy. A similar limitation applies to POU3F1, where an available mouse complex (PDB ID: 4Y60) was used to predict human protein–DNA interactions. Notably, DeepBind [9], a sequence-based prediction tool, also failed to distinguish strong from weak binders when using the mouse POU3F1 protein (AUC score: 0.457), but this was corrected with the human POU3F1 protein (AUC score: 0.956).

      IDEA also fails to fully resolve the binding preference of USF1. A closer examination of the HT-SELEX data reveals a lack of distinction among the sequences, as most sequences, including those with the lowest M-word (binding affinity) scores, contain the DNA-binding E-box sequence CACGTG. Therefore, USF1 represents a challenging example where the experimental data only consists of strong binders with limited variations in binding affinity, which likely results from differences in flanking sequences of the E-box motif.

      Egr1 stands as a peculiar example. Whereas IDEA does not effectively distinguish between the strong and weak binders in the current HT-SELEX dataset, its predictions are consistent with other experimental datasets, including binding affinities measured by k-MITOMI [42] (Figure S8A, B), preferred binding sequences from protein-binding microarray, an earlier HT-SELEX experiment, and bacterial one-hybrid data [43]. Therefore, further investigation of the current HT-SELEX data is needed to reconcile these differences.”

      Comment 7: It is also not clear if IDEA’s prediction for reverse complement sequences is the same for a given sequence. If so, how is this property being modelled? Either this description is lacking or I missed it.

      We thank the reviewer for the insightful comments. Given a target protein-DNA sequence, the IDEA protocol substitutes it into a known protein-DNA complex structure to evaluate the binding free energy, which can be converted into binding affinity. IDEA uses sequence identity to determine whether the forward or reverse strand of the DNA should be replaced. Only the strand most similar to the target sequence is substituted. As a result, the model treats reverse-complement sequences differently. As the orientations of test sequences are specified from 5’ to 3’ in all datasets used in this study (e.g., processed MITOMI, HT-SELEX, and ChIP-seq data), this approach ensures that the target sequences are replaced and evaluated correctly. In cases where sequence orientation is not provided (though this was not an issue in this study), we recommend replacing both the forward and reverse strands with the target sequence separately and evaluating the corresponding protein–DNA binding free energies. Since strong binders are likely to dominate the experimental signals, the higher predicted binding affinity, with stronger binding free energies, should be taken as the model’s final prediction.

      We have added one section to the Methods Section titled Treatment of Complementary DNA Sequences to clarify these modeling details.

      The specific text reads:

      To replace the DNA sequence in the protein-DNA complex structure with a target sequence, IDEA uses sequence identity to determine whether the target sequence belongs to the forward or reverse strand of the DNA in the proteinDNA structure. The more similar strand is selected and replaced with the target sequence. As the orientations of test sequences are specified from 5’ to 3’ in all datasets used in this study (e.g., processed MITOMI, HT-SELEX, and ChIP-seq data), this approach ensures that the target sequences are replaced and evaluated correctly. In cases where sequence orientation is not provided (though this was not an issue in this study), we recommend replacing both the forward and reverse strands with the target sequence separately and evaluating the corresponding protein–DNA binding free energies. Since strong binders are likely to dominate the experimental signals, the higher predicted binding affinity, with stronger binding free energy, should be taken as the model’s final prediction.”

      “Comment 8: Page 21 line 403, the E-box core should be CACGTG instead of CACGTC.

      We apologize for our oversight and have corrected the relevant text.

      Comment 9: The citation for DNAproDB is outdated and should be updated (PMID 39494533).

      We thank the reviewer for pointing this out and have updated our citation accordingly.

      Reviewer #3:

      Comment 0: Summary: Protein-DNA interactions and sequence readout represent a challenging and rapidly evolving field of study. Recognizing the complexity of this task, the authors have developed a compact and elegant model. They have applied well-established approaches to address a difficult problem, effectively enhancing the information extracted from sparse contact maps by integrating artificial sequences decoy set and available experimental data. This has resulted in the creation of a practical tool that can be adapted for use with other proteins.

      We appreciate the reviewer’s excellent summary of the paper, and we thank the reviewer for the insightful suggestions and comments.

      Comment 1: Strengths: (1) The authors integrate sparse information with available experimental data to construct a model whose utility extends beyond the limited set of structures used for training. (2) A comprehensive methods section is included, ensuring that the work can be reproduced. Additionally, the authors have shared their model as a GitHub project, reflecting their commitment to transparency of research.

      We appreciate the reviewer’s strong assessment of the strengths of this paper. In addition to sharing our model on GitHub, we have also uploaded the original data and the essential scripts required to reproduce the results presented in the manuscript. We hope this further demonstrates our commitment to transparency and reproducibility.

      Comment 2: Weaknesses: (1) The coarse-graining procedure appears artificial, if not confusing, given that full-atom crystal structures provide more detailed information about residue-residue contacts. While the selection procedure for distance threshold values is explained, the overall motivation for adopting this approach remains unclear. Furthermore, since this model is later employed as an empirical potential for molecular modeling, the use of P and C5 atoms raises concerns, as the interactions in 3SPN are modeled between Cα and the nucleic base, represented by its center of mass rather than P or C5 atoms.

      We appreciate the reviewer’s insightful comments. The selection of P and C5 atoms was based on different relative positions of protein and DNA across various complex structures, each with distinctive protein-DNA structural interfaces. To illustrate this, we selected two representative structures where our algorithm selected C5 and P atoms, respectively: MAX-DNA (PDB ID: 1HLO) and FOXP3 (PDB ID: 7TDW). As shown in Author response image 2, in the case of 1HLO, more C5 atoms are within the cutoff distance of 10 A from˚ the protein Cα atoms, thus capturing essential contacting interactions. In contrast, 7TDW has more P atoms within this cutoff. Importantly, several P atoms are distributed on the minor groove of the DNA, which were not captured by the C5 atoms. To maximize the inclusion of relevant structural contacts, we employed a filtering scheme that selectively chooses either P or C5 atoms based on their proximity to the protein to enhance the model prediction. We note that while this scheme is helpful, the IDEA predictions remain robust across different atom selections. To assess this robustness, we performed binding affinity predictions using only P atoms on the HT-SELEX dataset across 12 protein families [5]. Our predictions (Author response table 1) show comparable performance to that achieved using our filtering scheme.

      Author response image 2.

      Comparison between P and C5 atoms in proximity to the protein 3D structures of MAX–DNA (A) and FOXP-DNA (B) complexes, where P atoms (red sphere) and C5 atoms (blue sphere) that are within 10 A of Cα atoms are highlighted.

      When incorporating the trained IDEA energy model into a simulation model, we acknowledge a potential mismatch between the resolution of the data-driven model (one coarse-grained site per nucleotide) and the 3SPN simulation model (three coarse-grained sites per nucleotide). The selection of nucleic base sites for molecular interactions in the 3SPN model follows our previous work [44] and its associated code implementation. While revisiting this part of the manuscript, we identified an inconsistency in the reported results in Figure 5A of our initial version: Specifically, we previously used the protein side-chain atoms, rather than only the Cα atoms, in model training. Retraining the data using the Cα atoms results in reduced prediction performance for the IDEA model (Figure 5A). Nonetheless, incorporating this updated energy model into simulations still yielded high accuracy in the predicted absolute binding free energies (Author response image 3A), demonstrating the robustness of our simulation framework in predicting absolute binding free energies against variations in atom selection during the IDEA model training. Following the reviewer’s suggestion, we also incorporated the IDEA-trained energy model as short-range van der Waals interactions between protein Cα atoms and DNA P atoms. As shown in Author response image 3B, our simulation reveals a slightly improved performance over our original implementation, with higher Pearson and Spearman correlation coefficients and a fitted slope closer to 1.0. This result suggests that a more consistent atom selection scheme between the data-driven and simulation models can improve the overall predictions. Accordingly, we have updated Figure 5 with this improved setup, using the simulation model with short-range vdW interactions implemented between protein Cα atoms and DNA P atoms (Figure 5C), ensuring consistency between the IDEA model and simulation framework.

      Author response table 1.

      Comparison of IDEA performance using two DNA atom selection schemes: the filtering scheme presented in the manuscript (C5 and P atoms) versus using only P atoms. Cases where the two schemes result in different atom selections are highlighted in bold.

      We acknowledge that a gap still exists between the resolution of the data-driven and simulation models. To ensure a completely consistent coarse-grained level between these two models, we will work on implementing the IDEA model output for 1-bead-per-nucleotide DNA simulation models in the future.

      Comment 3: (2) Although the authors use a standard set of metrics to assess model quality and predictive power, some ∆∆G predictions compared to MITOMI-derived ∆∆G values appear nonlinear, which casts doubt on the interpretation of the correlation coefficient.

      Author response image 3.

      Comparison of simulations using different representative atoms (A) Protein-DNA binding simulation with the IDEA-model incorporated as short-range van der Waals between protein Cα atom and nucleic base site. (B) Protein-DNA binding simulation with the IDEA-model incorporated as short-range van der Waals between protein Cα atom and DNA P atoms. The predicted free energies are robust to the choice of DNA representative atoms. The predicted binding free energies are presented in physical units, and error bars represent the standard deviation of the mean.

      We thank the reviewer for the insightful comments and agree that the linear fit between our model’s prediction and the experimental data may not be the best measure of performance. The primary utility of the IDEA model is to predict high-affinity DNA-binding sequences for a given DNA-binding protein by assessing the relative binding affinities across different DNA sequences. In this regard, the ranked order of predicted sequence binding affinities serves as a better metric for evaluating the success of this model. To evaluate this, we calculated both Spearman’s rank correlation coefficient, which does not rely on linear correlation, and the Pearson correlation coefficient between our predictions and the experimental results. As shown in Figure 2, our computation shows a Spearman’s rank correlation coefficient of 0.65 for the MAX-based predictions using one MAX-DNA complex (PDB ID: 1HLO), supporting the model’s capability to effectively distinguish strong from weak binders.

      As reflected in Figure 2 of the main text, although our model generally captures the relative binding affinities across different DNA sequences, its predictive accuracy diminishes for low-affinity sequences (Figure 2). This could be due to two limitations of the current modeling framework: (1) The model is residue-based and estimates binding free energy as the additive sum of contributions from individual contacting amino-acid-nucleotide pairs. This assumption does not account for cooperative effects caused by simultaneous changes at multiple nucleotide positions. One potential direction to further improve the model would be to use a finer-grained representation by incorporating more atom types within contacting residues, and to use a many-body potential to better capture cooperative effects from multiple mutations. (2) The model assumes that the target DNA adopts the same binding interface as in the reference crystal structure. However, sequencedependent DNA shape has been shown to be important in determining protein-DNA binding affinity [1]. To address this limitation, a future direction is to use deep-learningbased methods to incorporate predicted DNA shape or protein-DNA complex structures based on their sequences [2, 3] into our model prediction.

      To fully evaluate the predictive power of IDEA, we have included Spearman’s rank correlation coefficient for every correlation plot in this manuscript. Across all our analyses, the Spearman’s rank correlation coefficients reveal similar predictive performance as the Pearson correlation coefficients. Additionally, we have included in our discussion the current limitations of our model and potential directions for future improvement.

      We have edited our Discussion Section to include a discussion on the limitations of the current model. Specifically, the added texts are:

      “Although IDEA has proved successful in many examples, it can be improved in several aspects. The model currently assumes the training and testing sequences share the same protein-DNA structure. While double-stranded DNA is generally rigid, recent studies have shown that sequence-dependent DNA shape contributes to their binding specificity [1, 2, 4]. To improve predictive accuracy, one could incorporate predicted DNA shapes or structures into the IDEA training protocol. In addition, the model is residue-based and evaluates the binding free energy as the additive sum of contributions from individual amino-acid-nucleotide contacts. This assumption does not account for cooperative effects that may arise from multiple nucleotide changes. A potential refinement could utilize a finer-grained model that includes more atom types within contacting residues and employs a many-body potential to account for such cooperative effects.”

      Comment 4: (3) The discussion section lacks information about the model’s limitations and a comprehensive comparison with other models. Additionally, differences in model performance across various proteins and their respective predictive powers are not addressed.

      We thank the reviewer for the insightful comments. As discussed in the response to Comment 3, the current structural model has several limitations, which may reduce predictive accuracy for weak DNA binders. We have noted these limitations in the Discussion section.

      To compare the performance of IDEA with state-of-the-art protein-DNA predictive models, we examined the predictive accuracies of two additional popular computational models: ProBound [8] and DeepBind [9]. ProBound has been shown to have a better performance than several earlier predictive protein-DNA models, including JASPAR 2018 [11], HOCOMOCO [12], Jolma et al. [13], and DeepSELEX [14]. To benchmark these models’ performance, we examine each method’s capability to identify strong binders with the HT-SELEX datasets covering 22 proteins from 12 protein families [5]. As suggested by Reviewer 1, we also calculated the PRAUC score, reweighted to account for data imbalance [6], as a complementary metric for evaluating the model performance.

      As shown in Figure S6, Table S1, and Table S2, IDEA ranked second among the three predictive methods. It is important to note that both ProBound and DeepBind were trained on a curated version of the HT-SELEX data [13], which overlaps with the testing data [5]. Compared with them, IDEA was trained only on the given structural and sequence information from a single protein-DNA complex, thus independent of the testing data. In order to assess how IDEA performs when incorporating knowledge from HT-SELEX data, we augmented the training by randomly including half of the HT-SELEX data (see the Methods Section Enhanced Modeling Prediction with SELEX Data). The augmented IDEA model achieved the best performance among all the models. We further benchmarked IDEA using a 10-fold cross-validation on the same HT-SELEX data [5] and found that IDEA outperformed a recent regression model that considers the shape of DNA with different sequences [5]. Overall, IDEA can be used to predict protein-DNA affinities in the absence of known binding sequence data, thereby filling a critical gap when such experimental datasets are unavailable.

      In addition, we compared the performance of IDEA with both general and family-specific knowledge-based energy models. First, we incorporated a knowledge-based generic protein-DNA energy model (DBD-Hunter) learned from the protein-DNA database, reported by Skoinick and coworkers [7], into our prediction protocol. This model assigns interaction energies to different functional groups within each DNA nucleotide (e.g., phosphate (PP), sugar (SU), pyrimidine (PY), and imidazole (IM) groups). For our comparison, we averaged the energy contributions of these groups within each nucleotide and replaced the IDEA-learned energy model with this generic one to test its ability to differentiate strong binders from weak binders in the HT-SELEX dataset [5]. As shown in Figure S6, the IDEA model generally achieves better performance than the generic energy model. Additionally, we compared IDEA with rCLAMPS, a family-specific energy model developed to predict protein-DNA binding specificity in the C2H2 and homeodomain families. As shown in Table S1 and Table S2, IDEA also shows better performance than rCLAMPS in most cases across the C2H2 and homeodomain families, demonstrating that it has better predictive accuracy than both family-specific and generic knowledge-based models.

      We have revised our text to include the comparison between IDEA and other predictive models. Specifically, we revised the text in Section: IDEA Generalizes across Various Protein Families.

      The revised text reads:

      “To examine IDEA’s predictive accuracy across different DNA-binding protein families, we applied it to calculate protein-DNA binding affinities using a comprehensive HT-SELEX dataset [5]. We focused on evaluating the capability of IDEA to distinguish strong binders from weak binders for each protein with an experimentally determined structure. We calculated the probability density distribution of the top and bottom binders identified in the SELEX experiment. A well-separated distribution indicates the successful identification of strong binders by IDEA (Figure 2D and S4). Receiver Operating Characteristic (ROC) analysis was performed to calculate the Area Under the Curve (AUC) and the precision-recall curve (PRAUC) scores for these predictions. Further details are provided in the Methods Section Evaluation of IDEA Prediction Using HT-SELEX Data. Our analysis shows that IDEA successfully differentiates strong from weak binders for 80% of the 22 proteins across 12 protein families, achieving AUC and balanced PRAUC scores greater than 0.5 (Figure 2E and S5). To benchmark IDEA’s performance against other leading methods, we compared its predictions with several popular models, including the sequence-based predictive models ProBound [8] and DeepBind [9], the familybased energy model rCLAMPS [10], and the knowledge-based energy model DBD-Hunter [7]. IDEA demonstrates performance comparable to these stateof-the-art approaches (Figure S6, Table S1, and Table S2), and incorporating sequence features further improves its prediction accuracy. We also performed 10-fold cross-validation on the binding affinities of protein–DNA pairs in this dataset and found that IDEA outperforms a recent regression model that considers the shape of DNA with different sequences [5] (Figure S7). Details are provided in Section: Comparison of IDEA predictive performance Using HT-SELEX data.”

      We also added one section Comparison of IDEA predictive performance Using HT-SELEX data in the Appendix to fully explain the comparison between IDEA and other popular models.

      The added texts are:

      “To benchmark the performance of IDEA against state-of-the-art protein-DNA predictive models, we evaluated its ability to recognize strong binders with the HT-SELEX datasets across 22 proteins from 12 families [5]. Specifically, we compare IDEA with two widely used sequence-based models: ProBound [8] and DeepBind [9]. ProBound has demonstrated superior performance over many other predictive protein-DNA models, including JASPAR 2018 [11], HOCOMOCO [12], Jolma et al. [13], and DeepSELEX [14]. To use ProBound, we retrieved the trained binding model for each protein from motifcentral.org and used the GitHub implementation of ProBoundTools to infer the binding scores between protein and target DNA sequences. Except for POU3F1, binding models are available for all proteins. Therefore, we excluded POU3F1 and evaluated the protein-DNA binding affinities for the remaining 21 proteins. To use DeepBind, sequence-specific binding affinities were predicted directly with its web server. The Area Under the Curve (AUC) and the Precision-Recall AUC (PRAUC) scores were used as metrics for comparison. An AUC score of 1.0 indicates a perfect separation between the strong- and weak-binder distributions, while an AUC score of 0.5 indicates no separation. Because there is a significant imbalance in the number of strong and weak binders from the experimental data [5], where the strong binders are far fewer than the weak binders, we reweighted the samples to achieve a balanced evaluation, using 0.5 as the baseline for randomized prediction [6]. As summarized in Figure S6, Table S1, and Table S2, IDEA ranked second among the three predictive models. In order to assess the performance of IDEA when augmented with additional protein-DNA binding data, we augmented IDEA using randomly selected half of the HT-SELEX data (see the Methods Section Enhanced Modeling Prediction with SELEX Data). The augmented IDEA model achieved the best performance among all the models.”

      “In addition, we compared the performance of IDEA with both general and family-specific knowledge-based energy models. First, we incorporated a knowledgebased generic protein-DNA energy model (DBD-Hunter) learned from the protein-DNA database, reported by Skoinick and coworkers [7], into our prediction protocol. This model assigns interaction energies to different functional groups within each DNA nucleotide, including phosphate (PP), sugar (SU), pyrimidine (PY), and imidazole (IM) groups. For our comparison, we averaged the energy contributions of these groups within each nucleotide and replaced the IDEA-learned energy model with the DBD-Hunter model to assess its ability to differentiate strong binders from weak binders in the HTSELEX dataset [5]. Additionally, we compared IDEA with rCLAMPS, a familyspecific energy model developed to predict protein-DNA binding specificity in the C2H2 and homeodomain families. rCLAMPS learns a position-dependent amino-acid-nucleotide interaction energy model. To incorporate this model into the binding free energy calculation, we averaged the energy contributions across all occurrences of each amino-acid-nucleotide pair, which resulted in a 20-by-4 residue-type-specific energy matrix. This matrix is structurally analogous to the IDEA-trained energy model and can be directly integrated into the binding free energy calculations. As shown in Figure S6, Table S1, and Table S2, the IDEA model generally outperforms DBD-Hunter and rCLAMPS, demonstrating that it can achieve better predictive accuracy than both generic and family-specific knowledge-based models.”

      “We also performed 10-fold cross-validation using the same HT-SELEX datasets, following the protocol described in the Methods Section Enhanced Modeling Prediction with SELEX Data. For each protein, we divided the entire dataset into 10 equal, randomly assigned folds. In each iteration, we used randomly selected 9 of the 10 folds as the training dataset and the remaining fold as the testing dataset. This process was repeated 10 times so that each fold served as the test set once. We then reported the average R2 scores across these iterations to evaluate IDEA’s predictive performance. Our results are compared with the 1mer and 1mer+shape methods from [5], the latest regression model that considers the shape of DNA with different sequences (Figure S7). This comparative analysis shows IDEA achieved higher predictive accuracy than the state-of-the-art sequence-based protein-DNA binding predictors for proteinDNA complexes that have available experimentally resolved structures.”

      “Overall, these results demonstrate that IDEA can be used to predict the proteinDNA pairs in the absence of known binding sequence data, thus filling an important gap in protein-DNA predictions when experimental binding sequence data are unavailable.”

      We also greatly appreciate the reviewer’s suggestion to examine the model’s performance across different proteins. To do this, we first evaluated the dependence of IDEA prediction on the availability of experimental structures similar to the target protein-DNA complexes. To quantitatively assess similarities and differences among the IDEA-derived energy models, we flattened each normalized energy model into an 80-dimensional vector and performed principal component analysis (PCA). As shown in Author response image 1 and Figure S11, energy models optimized from the same protein family fall within the same cluster, while those from different protein families exhibit distinct patterns. Moreover, the relative distance between energy models in PCA space reflects the degree of transferability. For example, PHO4 (PDB ID: 1A0A) is positioned close to MAX (PDB ID: 1HLO), whereas USF1 (PDB ID: 1AN4) and TCF4 (PDB ID: 6OD3) are farther away. This is consistent with the results shown in Figure 3A, where the energy model trained from PHO4 has better transferability than those from the other two systems. Therefore, the availability of experimental structures from protein-DNA complexes more similar to the target can lead to better predictive performance.

      We also examine cases in which the IDEA model failed to show strong discriminative power for protein-DNA complexes in the HT-SELEX datasets [5] (Figures 2E and S5). When evaluating the model’s ability to distinguish between strong and weak binders, we used the available experimental structure most similar to the protein employed in the HT-SELEX experiments. In some instances, only the structure of the same protein from a different organism is available. For example, the HT-SELEX data for PDX1-DNA used the human PDX1 protein, but no human PDX1–DNA complex structure is available. Therefore, we used the mouse PDX1–DNA complex (PDB ID: 2H1K) for model training. The differences between species may limit the predictive accuracy of the model. A similar limitation applies to POU3F1, where an available mouse complex (PDB ID: 4Y60) was used to predict human protein–DNA interactions. Notably, DeepBind [9], a sequencebased prediction tool, also failed to distinguish strong from weak binders when using the mouse POU3F1 protein (AUC score: 0.457), but this was corrected with the human POU3F1 protein (AUC score: 0.956).

      We also examined the remaining cases where IDEA did not show a clear distinction between strong and weak binders: USF1, Egr1, and PROX1. For PROX1, we initially used the structure of a protein-DNA complex (PDB ID: 4Y60) in training. However, upon closer inspection, we discovered that this structure does not include the PROX1 protein, but SOX-18, a different transcription factor. This explains the inaccurate prediction made by IDEA. Since no experimental PROX1-DNA complex structure is currently available, we have removed this case from our HT-SELEX evaluation.

      IDEA also fails to fully resolve the binding preference of USF1. A closer examination of the HT-SELEX data reveals a lack of distinction among the sequences, as most sequences, including those with the lowest M-word (binding affinity) scores, contain the DNA-binding E-box sequence CACGTG. Therefore, USF1 represents a challenging example where the experimental data only consists of strong binders with limited variations in binding affinity, which likely results from differences in flanking sequences of the E-box motif.

      Egr1 stands as a peculiar example. Whereas IDEA does not effectively distinguish between the strong and weak binders in the current HT-SELEX dataset, its predictions are consistent with other experimental datasets, including binding affinities measured by kMITOMI [42] (Figure S8A, B), preferred binding sequences from protein-binding microarray, an earlier HT-SELEX experiment, and bacterial one-hybrid data [43]. Therefore, further investigation of the current HT-SELEX data is needed to reconcile these differences.

      In summary, IDEA’s predictive performance depends on the availability of experimental structures closely related to the target protein-DNA complexes, both in terms of protein sequences and model organisms.

      We have included additional text in Section: IDEA Demonstrates Transferability across Proteins in the Same CATH Superfamily to discuss the PCA analysis and the dependence of the model’s transferability on the similarity among the learned energy models.

      The revised text now reads:

      “The transferability of IDEA within the same CATH superfamily can be understood from the similarities in protein-DNA binding interfaces, which determine similar learned energy models. For example, the PHO4 protein (PDB ID: 1A0A) shares a highly similar DNA-binding interface with the MAX protein (PDB ID: 1HLO) (Figure 3B), despite sharing only a 33.41% probability of being homologous. Consequently, the energy model derived from the PHO4DNA complex (Figure 3C) exhibits a similar amino-acid-nucleotide interactive pattern as that learned from the MAX-DNA complex (Figure 2B). To further evaluate the similarity between the learned energy models and their connection to protein families, we performed principal component analysis (PCA) on the normalized energy models across 24 proteins from 12 protein families [5]. Our analysis (Figure S11) reveals that most of the energy models from the same protein family fall within the same cluster, while those from different protein families exhibit distinct patterns. Moreover, the relative distance between energy models in PCA space reflects the degree of transferability between them. For example, PHO4 (PDB ID: 1A0A) is positioned close to MAX (PDB ID: 1HLO), whereas USF1 (PDB ID: 1AN4) and TCF4 (PDB ID: 6OD3) are farther away. This is consistent with the results in Figure 3A, where the energy model trained on PHO4 has better transferability than those trained on USF1 or TCF4.”

      We have also added an Appendix section titled Analysis of examples where IDEA fails to recognize strong DNA binders to discuss the examples in which IDEA did not perform well:

      “We examine IDEA’s capability in identifying strong binders from the HT-SELEX dataset across 12 protein families [5]. The model successfully predicts 18 out of 22 protein-DNA systems, but the performance is reduced in 4 cases. Closer investigations revealed the source of these limitations. In some instances, only the protein from a different organism is available. For example, the PDX1 HT-SELEX data utilized the human PDX1 protein, but no human PDX1–DNA complex structure is available. Therefore, the mouse PDX1–DNA complex structure (PDB ID: 2H1K) was used for model training. Differences between model organisms may reduce predictive accuracy. A similar limitation applies to POU3F1, where an available mouse complex (PDB ID: 4Y60) was used to predict human protein–DNA interactions. Notably, DeepBind [9], a sequence-based prediction tool, also failed to distinguish strong from weak binders when using the mouse POU3F1 protein (AUC score: 0.457), but this was corrected with the human POU3F1 protein (AUC score: 0.956).

      IDEA also fails to fully resolve the binding preference of USF1. A closer examination of the HT-SELEX data reveals a lack of distinction among the sequences, as most sequences, including those with the lowest M-word (binding affinity) scores, contain the DNA-binding E-box sequence CACGTG. Therefore, USF1 represents a challenging example where the experimental data only consists of strong binders with limited variations in binding affinity, which likely results from differences in flanking sequences of the E-box motif.

      Egr1 stands as a peculiar example. Whereas IDEA does not effectively distinguish between the strong and weak binders in the current HT-SELEX dataset, its predictions are consistent with other experimental datasets, including binding affinities measured by k-MITOMI [42] (Figure S8A, B), preferred binding sequences from protein-binding microarray, an earlier HT-SELEX experiment, and bacterial one-hybrid data [43]. Therefore, further investigation of the current HT-SELEX data is needed to reconcile these differences.”

      Comment 5: The authors provide an implementation of their model via GitHub, which is commendable. However, it unexpectedly requires the Modeller suite, despite no details about homology modeling being included in the methods section.

      We thank the reviewer for the helpful comments. We did not use the homology modeling module of Modeller. Instead, we only used a single Python script, buildseq.py, from the Modeller package to extract the protein and DNA sequences from the given PDB structure. We have clarified this in the README file on our GitHub repository.

      Comment 6: While the manuscript is written in clear and accessible English, some sentences are quite long and could benefit from rephrasing (e.g., lines 49-52).

      Thank you for the helpful suggestion. We agree that the original sentence was overly long and have revised it by splitting it into two for improved clarity and readability.

      The revised version reads:

      “The very robustness of evolution [46, 47, 48, 49] provides an opportunity to extract the sequence-structure relationships embedded in existing complexes. Guided by this principle, we can learn an interpretable binding energy landscape that governs the recognition processes of DNA-binding proteins.”

      Comment 7: In line 82, the citations appear out of place, as the context seems to suggest the use of the newly developed model.

      Thank you for this insightful suggestion. We have rephrased the sentence to better connect with the context of this section.

      The revised text now reads:

      “Finally, the learned energy model can be incorporated into a simulation framework to explore the dynamics of DNA-binding processes, revealing mechanistic insights into various DNA-templated processes.”

      Comment 8: Line 143 ”different structure from the bHLH TFs and thus requires a different atom” This is the first instance in the manuscript where the atom selection for distance thresholding is mentioned, making the text somewhat confusing.

      We thank the reviewer for the insightful comment and agree that the atom selection scheme appears abruptly in this section. To improve clarity, we have moved the detailed atom selection scheme and its rationale to the Methods Section titled Structural Modeling of Protein and DNA.

      Comment 9: Figures: Overall, the figures are visually appealing but could be further improved.

      We appreciate the positive feedback regarding the visual presentation of our figures. Following the reviewer’s suggestions and to further enhance clarity, we have revised several figures to improve labeling, layout, and annotations.

      Comment 10: Figure 1: The description ”highlighted in blue” considers changing to ”highlighted in blue on the structure.”.

      We have revised the text based on your suggestion.

      Comment 11: Figure 2: Panel B is missing a color bar legend and units, as is the case in Figure 3C. Additionally, the placement of Panel C is unconventional - it appears it should be Panel D. The color scheme for the spheres is not fully described. Panel E: There are too many colors used; consider employing different markers to improve clarity.

      Thank you for the helpful suggestions.

      For Figure 2B and Figure 3C, we would like to clarify that the predicted energies are presented in reduced units due to an undetermined prefactor introduced during the model optimization. This point has now been clarified in the figure captions and is also explained in the Methods section titled Training Protocol.

      Additionally, we have rearranged Panels C and D to improve the figure layout and have fully described the color coding used in the structural representations.

      We have updated it to read:

      “Results for MAX-based predictions. (A) The binding free energies calculated by IDEA, trained using a single MAX–DNA complex (PDB ID: 1HLO), correlate well with experimentally measured MAX–DNA binding free energies [50]. ∆∆G represents the changes in binding free energy relative to that of the wild-type protein–DNA complex. (B) The heatmap, derived from the optimized energy model, illustrates key amino acid–nucleotide interactions governing MAX–DNA recognition, showing pairwise interaction energies between 20 amino acids and the four DNA bases—DA (deoxyadenosine), DT (deoxythymidine), DC (deoxycytidine), and DG (deoxyguanosine). Both the predicted binding free energies and the optimized energy model are expressed in reduced units, as explained in the Methods Section Training Protocol. Each cell represents the optimized energy contribution, where blue indicates more favorable (lower) energy values, and red indicates less favorable (higher) values. (C) The 3D structure of the MAX–DNA complex (zoomed in with different views) highlights key amino acid–nucleotide contacts at the protein–DNA interface. Notably, several DNA deoxycytidines (red spheres) form close contacts with arginines (blue spheres). Additional nucleotide color coding: adenine (yellow spheres), guanine (green spheres), thymine (pink spheres). (D) Probability density distributions of predicted binding free energies for strong (blue) and weak (red) binders of the protein ZBTB7A. The mean of each distribution is marked with a dashed line. (E) Summary of AUC scores for protein–DNA pairs across 12 protein families, calculated based on the predicted probability distributions of binding free energies.”

      We fully agree that Panel E was visually overwhelming. We have revised the plot by using a combination of color and marker shapes to more clearly distinguish between different protein families, as suggested.

      Comment 12: Typos:

      Line 18: Gene expressions → Gene expression?

      Line 28: performed → utilized ?

      We really appreciate the suggestions and have corrected the text accordingly.

      References

      (1) Tianyin Zhou, Ning Shen, Lin Yang, Namiko Abe, John Horton, Richard S Mann, Harmen J Bussemaker, Raluca Gordan, and Remo Rohs. Quantitative modeling ofˆ transcription factor binding specificities using DNA shape. Proceedings of the National Academy of Sciences, 112(15):4654–4659, 2015.

      (2) Jinsen Li, Tsu-Pei Chiu, and Remo Rohs. Predicting DNA structure using a deep learning method. Nat Commun, 15(1):1243, February 2024.

      (3) Josh Abramson, Jonas Adler, Jack Dunger, Richard Evans, Tim Green, Alexander Pritzel, Olaf Ronneberger, Lindsay Willmore, Andrew J. Ballard, Joshua Bambrick, Sebastian W. Bodenstein, David A. Evans, Chia-Chun Hung, Michael O’Neill, David Reiman, Kathryn Tunyasuvunakool, Zachary Wu, Akvile˙ Zemgulytˇ e, Eirini Arvan-˙ iti, Charles Beattie, Ottavia Bertolli, Alex Bridgland, Alexey Cherepanov, Miles Congreve, Alexander I. Cowen-Rivers, Andrew Cowie, Michael Figurnov, Fabian B. Fuchs, Hannah Gladman, Rishub Jain, Yousuf A. Khan, Caroline M. R. Low, Kuba Perlin, Anna Potapenko, Pascal Savy, Sukhdeep Singh, Adrian Stecula, Ashok Thillaisundaram, Catherine Tong, Sergei Yakneen, Ellen D. Zhong, Michal Zielinski, Augustin Zˇ´ıdek, Victor Bapst, Pushmeet Kohli, Max Jaderberg, Demis Hassabis, and John M. Jumper. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature, pages 1–3, May 2024.

      (4) Raktim Mitra, Jinsen Li, Jared M. Sagendorf, Yibei Jiang, Ari S. Cohen, Tsu-Pei Chiu, Cameron J. Glasscock, and Remo Rohs. Geometric deep learning of protein–DNA binding specificity. Nat Methods, 21(9):1674–1683, September 2024.

      (5) Lin Yang, Yaron Orenstein, Arttu Jolma, Yimeng Yin, Jussi Taipale, Ron Shamir, and Remo Rohs. Transcription factor family-specific DNA shape readout revealed by quantitative specificity models. Mol Syst Biol, 13(2):910, February 2017.

      (6) Takaya Saito and Marc Rehmsmeier. The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets. PLoS ONE, 10(3):e0118432, March 2015.

      (7) Mu Gao and Jeffrey Skolnick. DBD-Hunter: a knowledge-based method for the prediction of DNA-protein interactions. Nucleic Acids Res, 36(12):3978–3992, July 2008.

      (8) H. Tomas Rube, Chaitanya Rastogi, Siqian Feng, Judith F. Kribelbauer, Allyson Li, Basheer Becerra, Lucas A. N. Melo, Bach Viet Do, Xiaoting Li, Hammaad H. Adam, Neel H. Shah, Richard S. Mann, and Harmen J. Bussemaker. Prediction of protein–ligand binding affinity from sequencing data with interpretable machine learning. Nat Biotechnol, 40(10):1520–1527, October 2022.

      (9) Babak Alipanahi, Andrew Delong, Matthew T Weirauch, and Brendan J Frey. Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning. Nat Biotechnol, 33(8):831–838, August 2015.

      (10) Joshua L. Wetzel, Kaiqian Zhang, and Mona Singh. Learning probabilistic proteinDNA recognition codes from DNA-binding specificities using structural mappings. Genome Res, 32(9):1776–1786, September 2022.

      (11) Aziz Khan, Oriol Fornes, Arnaud Stigliani, Marius Gheorghe, Jaime A CastroMondragon, Robin van der Lee, Adrien Bessy, Jeanne Cheneby, Shubhada R Kulka-` rni, Ge Tan, Damir Baranasic, David J Arenillas, Albin Sandelin, Klaas Vandepoele, Boris Lenhard, Benoˆıt Ballester, Wyeth W Wasserman, Franc¸ois Parcy, and Anthony Mathelier. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Research, 46(D1):D260–D266, January 2018.

      (12) Ivan V. Kulakovskiy, Ilya E. Vorontsov, Ivan S. Yevshin, Ruslan N. Sharipov, Alla D. Fedorova, Eugene I. Rumynskiy, Yulia A. Medvedeva, Arturo Magana-Mora, Vladimir B. Bajic, Dmitry A. Papatsenko, Fedor A. Kolpakov, and Vsevolod J. Makeev. HOCOMOCO: towards a complete collection of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis. Nucleic Acids Res, 46(D1):D252–D259, January 2018.

      (13) Arttu Jolma, Jian Yan, Thomas Whitington, Jarkko Toivonen, Kazuhiro R. Nitta, Pasi Rastas, Ekaterina Morgunova, Martin Enge, Mikko Taipale, Gonghong Wei, Kimmo Palin, Juan M. Vaquerizas, Renaud Vincentelli, Nicholas M. Luscombe, Timothy R. Hughes, Patrick Lemaire, Esko Ukkonen, Teemu Kivioja, and Jussi Taipale. DNABinding Specificities of Human Transcription Factors. Cell, 152(1-2):327–339, January 2013.

      (14) Maor Asif and Yaron Orenstein. DeepSELEX: inferring DNA-binding preferences from HT-SELEX data using multi-class CNNs. Bioinformatics, 36(Supplement 2):i634–i642, December 2020.

      (15) Oriol Fornes, Alberto Meseguer, Joachim Aguirre-Plans, Patrick Gohl, Patricia M Bota, Ruben Molina-Fernandez, Jaume Bonet, Altair Chinchilla-Hernandez, Ferran´ Pegenaute, Oriol Gallego, Narcis Fernandez-Fuentes, and Baldo Oliva. Structurebased learning to predict and model protein–DNA interactions and transcriptionfactor co-operativity in cis -regulatory elements. NAR Genomics and Bioinformatics, 6(2):lqae068, April 2024.

      (16) Sofia Aizenshtein-Gazit and Yaron Orenstein. DeepZF: improved DNA-binding prediction of C2H2-zinc-finger proteins by deep transfer learning. Bioinformatics, 38(Suppl 2):ii62–ii67, September 2022.

      (17) Stephen K Burley, Charmi Bhikadiya, Chunxiao Bi, Sebastian Bittrich, Henry Chao, Li Chen, Paul A Craig, Gregg V Crichlow, Kenneth Dalenberg, Jose M Duarte, Shuchismita Dutta, Maryam Fayazi, Zukang Feng, Justin W Flatt, Sai Ganesan, Sutapa Ghosh, David S Goodsell, Rachel Kramer Green, Vladimir Guranovic, Jeremy Henry, Brian P Hudson, Igor Khokhriakov, Catherine L Lawson, Yuhe Liang, Robert Lowe, Ezra Peisach, Irina Persikova, Dennis W Piehl, Yana Rose, Andrej Sali, Joan Segura, Monica Sekharan, Chenghua Shao, Brinda Vallat, Maria Voigt, Ben Webb, John D Westbrook, Shamara Whetstone, Jasmine Y Young, Arthur Zalevsky, and Christine Zardecki. RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning. Nucleic Acids Research, 51(D1):D488–D508, November 2022.

      (18) Raktim Mitra, Ari S. Cohen, Jared M. Sagendorf, Helen M. Berman, and Remo Rohs. DNAproDB: an updated database for the automated and interactive analysis of protein-DNA complexes. Nucleic Acids Res, 53(D1):D396–D402, January 2025.

      (19) Natalia Petrenko, Yi Jin, Liguo Dong, Koon Ho Wong, and Kevin Struhl. Requirements for RNA polymerase II preinitiation complex formation in vivo. eLife, 8:e43654, January 2019.

      (20) Rudolf Jaenisch and Adrian Bird. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet, 33(3):245–254, March 2003.

      (21) Claire Marchal, Jiao Sima, and David M. Gilbert. Control of DNA replication timing in the 3D genome. Nat Rev Mol Cell Biol, 20(12):721–737, December 2019.

      (22) Lucia A. Hindorff, Praveen Sethupathy, Heather A. Junkins, Erin M. Ramos, Jayashri P. Mehta, Francis S. Collins, and Teri A. Manolio. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proceedings of the National Academy of Sciences, 106(23):9362–9367, June 2009.

      (23) Tuuli Lappalainen, Alexandra J Scott, Margot Brandt, and Ira M Hall. Genomic analysis in the age of human genome sequencing. Cell, 177(1):70–84, 2019.

      (24) Sonali Mukherjee, Michael F. Berger, Ghil Jona, Xun S. Wang, Dale Muzzey, Michael Snyder, Richard A. Young, and Martha L. Bulyk. Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays. Nat Genet, 36(12):1331– 1339, December 2004.

      (25) Shaoxun Liu, Pilar Gomez-Alcala, Christ Leemans, William J. Glassford, Lucas A. N. Melo, Xiang-Jun Lu, Richard S. Mann, and Harmen J. Bussemaker. Predicting the DNA binding specificity of transcription factor mutants using family-level biophysically interpretable machine learning. bioRxiv, page 2024.01.24.577115, April 2025.

      (26) Tsu-Pei Chiu, Satyanarayan Rao, and Remo Rohs. Physicochemical models of protein–DNA binding with standard and modified base pairs. Proc. Natl. Acad. Sci. U.S.A., 120(4):e2205796120, January 2023.

      (27) Matthew T Weirauch, Atina Cote, Raquel Norel, Matti Annala, Yue Zhao, Todd R Riley, Julio Saez-Rodriguez, Thomas Cokelaer, Anastasia Vedenko, Shaheynoor Talukder, and others. Evaluation of methods for modeling transcription factor sequence specificity. Nature biotechnology, 31(2):126–134, 2013.

      (28) Chaitanya Rastogi, H. Tomas Rube, Judith F. Kribelbauer, Justin Crocker, Ryan E. Loker, Gabriella D. Martini, Oleg Laptenko, William A. Freed-Pastor, Carol Prives, David L. Stern, Richard S. Mann, and Harmen J. Bussemaker. Accurate and sensitive quantification of protein-DNA binding affinity. Proc. Natl. Acad. Sci. U.S.A., 115(16), April 2018.

      (29) Rahmatullah Roche, Bernard Moussad, Md Hossain Shuvo, Sumit Tarafder, and Debswapna Bhattacharya. EquiPNAS: improved protein–nucleic acid binding site prediction using protein-language-model-informed equivariant deep graph neural networks. Nucleic Acids Research, 52(5):e27–e27, March 2024.

      (30) Yufan Liu and Boxue Tian. Protein–DNA binding sites prediction based on pretrained protein language model and contrastive learning. Briefings in Bioinformatics, 25(1):bbad488, November 2023.

      (31) Binh P. Nguyen, Quang H. Nguyen, Giang-Nam Doan-Ngoc, Thanh-Hoang Nguyen-Vo, and Susanto Rahardja. iProDNA-CapsNet: identifying protein-DNA binding residues using capsule neural networks. BMC Bioinformatics, 20(S23):634, December 2019.

      (32) Trevor Siggers and Raluca Gordan. Protein–DNA binding: complexities and multi-ˆ protein codes. Nucleic Acids Research, 42(4):2099–2111, February 2014.

      (33) Johannes Soding, Andreas Biegert, and Andrei N. Lupas. The HHpred interactive¨ server for protein homology detection and structure prediction. Nucleic Acids Research, 33(suppl 2):W244–W248, July 2005.

      (34) William Humphrey, Andrew Dalke, and Klaus Schulten. VMD – Visual Molecular Dynamics. Journal of Molecular Graphics, 14:33–38, 1996.

      (35) Arttu Jolma, Teemu Kivioja, Jarkko Toivonen, Lu Cheng, Gonghong Wei, Martin Enge, Mikko Taipale, Juan M Vaquerizas, Jian Yan, Mikko J Sillanpa¨a, and others.¨ Multiplexed massively parallel SELEX for characterization of human transcription factor binding specificities. Genome research, 20(6):861–873, 2010.

      (36) Nobuo Ogawa and Mark D Biggin. High-throughput SELEX determination of DNA sequences bound by transcription factors in vitro. Gene Regulatory Networks: Methods and Protocols, pages 51–63, 2012.

      (37) Alina Isakova, Romain Groux, Michael Imbeault, Pernille Rainer, Daniel Alpern, Riccardo Dainese, Giovanna Ambrosini, Didier Trono, Philipp Bucher, and Bart Deplancke. SMiLE-seq identifies binding motifs of single and dimeric transcription factors. Nature methods, 14(3):316–322, 2017.

      (38) Paul G. Giresi, Jonghwan Kim, Ryan M. McDaniell, Vishwanath R. Iyer, and Jason D. Lieb. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res., 17(6):877–885, January 2007.

      (39) Peter J Park. ChIP–seq: advantages and challenges of a maturing technology. Nature reviews genetics, 10(10):669–680, 2009.

      (40) Terrence S. Furey. ChIP–seq and beyond: new and improved methodologies to detect and characterize protein–DNA interactions. Nat Rev Genet, 13(12):840–852, December 2012.

      (41) Anna Bartlett, Ronan C. O’Malley, Shao-shan Carol Huang, Mary Galli, Joseph R. Nery, Andrea Gallavotti, and Joseph R. Ecker. Mapping genome-wide transcriptionfactor binding sites using DAP-seq. Nat Protoc, 12(8):1659–1672, August 2017.

      (42) Marcel Geertz, David Shore, and Sebastian J Maerkl. Massively parallel measurements of molecular interaction kinetics on a microfluidic platform. Proceedings of the National Academy of Sciences, 109(41):16540–16545, 2012.

      (43) Gary D. Stormo and Yue Zhao. Determining the specificity of protein–DNA interactions. Nat Rev Genet, 11(11):751–760, November 2010.

      (44) Xingcheng Lin, Rachel Leicher, Shixin Liu, and Bin Zhang. Cooperative DNA looping by PRC2 complexes. Nucleic Acids Research, 49(11):6238–6248, June 2021.

      (45) P. L. Privalov, A. I. Dragan, and C. Crane-Robinson. Interpreting protein/DNA interactions: distinguishing specific from non-specific and electrostatic from nonelectrostatic components. Nucleic Acids Research, 39(7):2483–2491, April 2011.

      (46) J D Bryngelson and P G Wolynes. Spin glasses and the statistical mechanics of protein folding. Proc. Natl. Acad. Sci. U.S.A., 84(21):7524–7528, November 1987.

      (47) J. N. Onuchic, Z. Luthey-Schulten, and P. G. Wolynes. Theory of protein folding: the energy landscape perspective. Annu Rev Phys Chem, 48:545–600, 1997.

      (48) N. P. Schafer, B. L. Kim, W. Zheng, and P. G. Wolynes. Learning To Fold Proteins Using Energy Landscape Theory. Isr J Chem, 54(8-9):1311–1337, August 2014.

      (49) Wen-Ting Chu, Zhiqiang Yan, Xiakun Chu, Xiliang Zheng, Zuojia Liu, Li Xu, Kun Zhang, and Jin Wang. Physics of biomolecular recognition and conformational dynamics. Rep. Prog. Phys., 84(12):126601, December 2021.

      (50) Sebastian J. Maerkl and Stephen R. Quake. A Systems Approach to Measuring the Binding Energy Landscapes of Transcription Factors. Science, 315(5809):233–237, January 2007.

  2. Aug 2022
    1. HoaLacManThien Đã tốn tiền Jul 15, 2020 Edit bookmark #4 Review trực tiếp trong topic (đa phần là khách muốn bảo mật thông tin nên ở đây chỉ có 1 phần nhỏ vào review ủng hộ): VC MOD CÙNG ĐK :sexy:​ waterfall;108468173 said: Mình bằng tuổi Phong nhưng vì Phong quá siêu việt nên mình gọi bằng anh Có thể nói case của mình khá khó nhằn vì mình đã có gia đình chồng con, công việc lại hoạt động trong môi trường đông lao động và việc khó nên việc tư vấn cho mình phải nói rất phức tạp, không hề đơn giản nếu không có kiến thức vững chắc về xã hội, tâm lý học và đầu óc logic, phân tích. Mình thử dịch vụ của anh 6 tháng với phí là 600k, so với chất lượng dịch vụ và nhiệt tình mình nhận được thật là quá rẻ. Hết thời hạn này mình sẽ hợp tác dài hạn với anh, cũng không hẳn sau này mình sẽ tiếp tục cần dịch vụ của anh nhưng mình mến anh, coi anh là một người bạn mới. Chúc anh năm mới nhiều sức khoẻ, hạnh phúc, nhiều may mắn và thành công trong cuộc sống cũng như trong công việc. *tung hoa* Click to expand... Mr2006;110035709 said: Review chúc mừng sinh nhật em Phong (ManHoa) cái nào !!! Ca của mình khá là khó nhai vì có rất nhiều vấn đề cần phải giải quyết, cả hai vợ chồng đều sử dụng dịch vụ của Phong, tuy nhiên vấn đề bảo mật thông tin mà Phong cam kết mình nhận thấy rất tốt. Sau Tết mình bắt đầu sử dụng dịch vụ của em Phong, giờ được 10 ngày rồi, thời gian ngắn nhưng mình đã có những bước tiến rõ rệt, thay đổi bản thân theo hướng tích cực hơn (mình là người khá ù lỳ), dám quyết định và thử nghiệm những thứ mới mà trước giờ mình không nghĩ sẽ thử. Mọi thứ hiện tại đang phát triển theo chiều hướng rất tốt. Với mức giá Phong đưa ra mình thấy quá rẻ cho dịch vụ chất lượng như vậy. Ưu điểm: - Nắm bắt vấn đề nhanh. - Đưa ra những nhận xét và lời khuyên phù hợp. - Nhiệt tình, tư vấn chu đáo, gửi tài liệu tham khảo có tâm lắm ( you know what i mean Phong ^^) - Khả năng phân tích tâm lý và phán đoán tính cách tốt. - Dẫn dắt để giải quyết vấn đề cực kỳ hợp lý. Khuyết điểm: - Giờ giấc hơi bất thường, có thể thông cảm vì còn có công việc riêng. - Hành tung bí ẩn quá ))) Click to expand... CÁC AE KHÁC​ James Bond no.1;108492309 said: Cũng là khách hàng của anh Phong suốt 11 tháng. Nhưng không biết viết review như thế nào. Viết ngắn thì không hết , viết dài lại lan man. Nói tóm lại anh Phong tư vấn rất tốt. Không biết anh Phong thì sao nhưng nhiều lúc bản thân xem anh Phong như người anh lớn, tâm sự đc, chia sẻ đc, tư vấn đc chứ ko hẳn là hợp đồng thuê hay gì nữa. Có những điều anh Phong đã nói , đã định hướng nhưng phải đến khi bản thân trải nghiệm thực sự, nếm qua khoảnh khắc đó rồi ngẫm lại mới thấy "à ườm thì ra là thế, thì ra anh Phong nói đúng" , chứ có những việc nhiều khi bạn đã vấp ngã nhưng nếu ko ai định hướng trước thì chưa chắc đã nhận ra đâu. Vẫn nể anh Phong ở đầu óc sắc lẹm , tư duy logic và xâu chuỗi vấn đề rất tốt. Click to expand... Bác Sỹ Tâm Lý.;108522485 said: Nhân ngày đầu năm viết ít dòng review với cũng gọi là khai phím Đầu tiên phải nói là thím Manhoa nắm bắt tình hình cũng như phân tích các trường hợp, bắt bệnh cực kì chính xác. Mặc dù chỉ là chat qua FB hay skype cộng thêm thông tin nhỏ giọt (điểm này xin lỗi thím vì tính mình giờ đa nghi nên cũng muốn thử tay nghề). Thứ 2 là việc thím tư vấn thì rất là sát tình hình, cá nhân mình cảm thấy còn tốt nhiều so với Khánh wingman hay Nexx, Joker của Alpha art ngày xưa. Điểm này do thím Manhoa tập trung đi vào cốt lõi vấn đề, cách biến nguy thành an 1 cách thận trọng và vững chắc chứ ko phải là các chiêu trò ngắn hạn để dụ gái lên giường nhanh nhất. Bản thân mình từ lúc bắt đầu chương trình tư vấn tới giờ thật ra vẫn tự tin pick up gái các kiểu nhưng thím Manhoa đã cho mình thấy cốt lõi là cải thiện bản thân và nâng cao giá trị chính mình. Lời khuyên cho thím nào thật sự muốn tán đổ người mình thật sự yêu mến, muốn giữ vững mối quan hệ, muốn làm điều gì đó thật sự có ý nghĩa cho ngừi mình yêu quý thì hãy tìm đến thím manhoa. Còn nếu mua vui 1, 2 trống canh thì thôi bỏ qua đọc mấy cái tricks dạy tán gái cho nhanh. Click to expand... chuyenkhonghi;108528917 said: Đầu xuân cũng gõ vài dòng chúc mừng năm mới với bác ManHoa (Phong) và cũng đưa ra vài ý kiến về dịch vụ của bác. Nhiều người cũng đã review cụ thể và chi tiết, mình chỉ bổ sung là bác Manhoa này có khả năng đọc vị (đối tượng, tình huống,...) cực nhanh và chuẩn , và đưa ra hướng xử lý cực chuẩn và nhanh, rất cụ thể và sát đáng. Nói thực là điều này cực kỳ quan trọng cho mọi người trong quá trình chinh phục đối tượng ( tất nhiên đang xét mọi người đang có vấn đề khúc mắc chứ ko phải cao thủ rồi) bởi lẽ khi ở trong cuộc thì thường rất khó kiểm soát được cảm xúc, dù bạn có lý trí, có lý thuyết như thế nào. Có bác Manhoa tư vấn đảm bảo mọi người sẽ luôn có sự xử trí các tình huống chuẩn nhất, và đặc biệt là các tư vấn gỡ rối khi mọi người lỡ có các xử lý tình huống bị lố. Nhiều khi chỉ một vài xử lý, một vài tình huống trong quá trình chinh phục đối tượng thiếu tỉnh táo, bị chi phối nhiều bởi cảm xúc, dẫn tới tâm lý bi quan thì đã khiến mọi người dễ dàng chấm dứt mqh rồi, nên nếu có bác Man hoa mọi người yên tâm là đến ngay khi gameover thì vẫn có thể xoay ngược replay lại được. Ngoài ra thì cũng khuyến cáo mọi người nên xác định sử dụng dịch vụ nghiêm túc thì nên tham gia thì sẽ có hiệu quả nhất. Thú thực bác Manhoa nói nhiều cái mà thời gian càng diễn ra nó càng ngấm và nghĩ lại thấy thực sự chuẩn xác nên quả thực mình cũng ko cải thiện được nhiều như đã kỳ vọng do không thực hiện theo. Sau cùng thì mục đích tham gia ban đầu của mình đã không đạt được nhưng bác Manhoa đã tư vấn nhiệt tình, xác đáng, cho mình nhiều suy nghĩ tốt hơn, rất đáng khi sử dụng dịch vụ. Mọi người nếu sử dụng dịch vụ nên nhờ bác ấy tư vấn về định hướng phát triển bản thân và cố gắng thực hiện theo định hướng này để có hiệu quả cao nhất. Click to expand... Boy Girl Love;108437969 said: Mình cũng khá là thích cách anh Man Hoa tư vấn. Giá cả hợp lí. Về mặt chuyên môn cũng rất tốt và nhiệt tình. Ngày xưa nói chuyện với gái ngu lắm, gặp gái mà toàn nói chuyện thời sự, kinh tế, h thì đỡ rồi. Nhờ anh mà mình cũng bớt ác cảm với các cô gái đẹp mà kiểu chảnh chảnh với hay coi thường tấm lòng của người khác, và cũng học được cách chảnh lại với tụi nó :sexy::sexy: Tự tin hơn khi giao tiếp với chị em phụ nữ và tự tin hơn khi mình muốn tiếp cận với cô gái mình thích Mình cũng phải công nhận là anh có sự hiểu biết rộng về các ngành nghề, đặc biệt là mảng sale và cách giao tiếp với cấp trên, nhờ anh mà mình bít cách xử lí công việc và các mối quan hệ xung quanh ổn hơn. Em ở Sài Gòn nên cũng chưa có dịp gặp anh trực tiếp, nếu có dịp thì anh xuống Sài Gòn chơi nhé, anh em mình đi nhậu 1 bữa Click to expand... Dark0710;109042193 said: Ngắn gọn: Nhanh bổ rẻ. Tư vấn nhiệt tình, mỗi tội thỉnh thoảng bận vẽ quá nên quên lịch hẹn Còn lại chất lượng dịch vụ rất tốt Click to expand... Cut Win;109148805 said: Sau 6 tháng sử dụng dịch vụ của bác ManHoa,cảm thấy rất hài lòng,tư vấn nhiệt tình,phân tích chi tiết, có thể nói là thông não cho 1 đứa đầu đất như mình, tuy nhiên thỉnh thoảng chờ bác rep lâu (bận việc hay tư vấn ca khác), nếu bác cải thiện được thì đúng là tuyệt vời ông mặt trời. Click to expand... lymieu;108361281 said: Thấy có nhiều bạn hỏi về chất lượng dịch vụ của a Man Hoa, ngày làm việc cuối cùng cũng hơi rảnh nên mình tiện tay viết cái review luôn cho các bạn tham khảo. Nói thế nào nhỉ?! Hồi đầu mục đích mình muốn nhờ anh í tư vấn là để tán đc 2 mối mình đang để ý, nhưng sau khi trao đổi (kể hết tất tần tật những vấn đề khúc mắc đang gặp phải trong những mối quan hệ đó), thì mình dần nhận ra được 1 đối tượng chắc chắn không phù hợp với tính cách, công việc, và môi trường sống của mình nên thôi. Đối tượng còn lại thì mình ko còn bị chi phối cảm xúc nhiều nữa. Nếu như trước đây mình cứ bi luỵ kiểu chờ ngta onl, hay mỗi lần ngta inbox thì mừng hú lên, hay hở tí là inbox người ta, thì bây giờ không còn điều đó nữa. Vì sao? vì bây h mình đã nhận ra được giá trị của bản thân mình, hiểu rõ cái mình cần và cái mình muốn, cũng như định hình được đối tượng mình đang theo đuổi, nó thuộc cái thể nào, và có thực sự xứng đáng để mình phải hi sinh tiêu tốn nhiều thời gian, công sức, cũng như hạ thấp bản thân để theo đuổi hay ko Ngoài ra, mình cũng học được cách xây dựng và hoàn thiện bản thân hơn. Thỉnh thoảng có rắc rối trong công việc, về đợt review tăng lương, hay đòi quyền lợi khi đi công tác, hay những xung đột với đồng nghiệp , cũng được anh ấy tư vấn nhiệt tình. Bây giờ mình cảm giác như mình được lột xác hoàn toàn, mặc dù trước đây tư chất của mình sẵn đã tốt, nhưng mình ko nhận ra và cứ sống tự kỉ, thì giờ đã khác, mình cũng tự tin hơn rất nhiều Hi vọng năm mới này a Man Hoa sẽ tiếp tục đồng hành để giúp đỡ em. Cuối năm xin dành lời chúc chân thành và tốt đẹp nhất đến anh và gia đình. Click to expand... blackmask08;108362277 said: Đáng đồng tiền nhé bạn, mặc dù mình đăng ký tư vấn có khi 1,2 tháng mới hỏi tư vấn 1 lần. Tư vấn nhiệt tình, rút được nhiều kinh nghiệm cho những lần sau. Có lần mình quen gái được 1 tháng (nói chung là x y mà chưa tới z), rồi gái kêu ko muốn quen nữa. Lý do lãng nhách là không muốn chung sống với ba mẹ chồng, không thích ở gần nhà họ hàng (do họ hàng của gái ở gần nhà mình). Lên hỏi bác Hoathien tư vấn liền. Sau vài ngày được tư vấn gái chủ động liên lạc lại, mình cũng đi lại được hơn 1 tuần rồi mình không muốn quen tìm hiểu gái này gì nữa (suốt ngày đòi chia tay, gia đình này nọ) nên mình out luôn. Có lần gái kia, mình đang trong thế giằng co, có nên gọi điện thoại cho gái không, vì nhắn tin mà gái không trả lời. Rồi cũng được tư vấn vượt qua bể khổ mặc dù giờ này chưa có người yêu. Đầu óc sẽ được khai sáng, cách ăn nói, vì không những dùng để quen gái, gỡ vướng mắc mà còn dùng nhiều trong lĩnh vực khác. Click to expand... Minhchien27071995;108394341 said: Cuối năm vào viết vài dòng cảm nhận về dịch vụ của thím Phong Trước khi đăng kí tư vấn thì em cũng yêu đương nhiều rồi,về khoản tình yêu tình báo khá là tự tin Nhưng khi trao đổi với thím ấy,càng trao đổi càng thấy mình còn non nớt quá,vỡ vạc ra được nhiều điều Em hỏi cả nhiều vấn đề ngoài lề và rất thỏa mãn với các lời khuyên của thím ấy Chốt lại là năm mới chúc anh em mạnh khỏe,tán được nhiều gái Chúc thím Phong công tác tốt,viết được nhiều tài liệu đáng giá Click to expand... pessicoca7up;108426633 said: Cuối năm làm cái review nhanh cho mọi người, dv tư vấn tc thì mình chưa thử sang năm nhất đinh thử, mình đk a manhoa dv phát triển bản thân thấy rất tốt mình thấy những thím có những khiếm khuyết tâm lý, hoặc sv đang học mà ko định hướng lười học bỏ bê chán nản nên đk 1 khóa tư vấn để cải thiện về mặt tâm lý,lấy lại đc động lực học tập để có tương lai hơn.Cuối năm e cũng chúc a mạnh khỏe hy vọng hoàn thành xong bộ sách cho mọi người để hoàn thiện mình hơn nữa. Click to expand... fuok_vo;108385413 said: mình rv chút về cách tư vấn của thím Phong:sexy: Nhiệt tình, giải thích dễ hiểu và cách giải thích của bác khác với mấy cái các thím từng đọc trên mạng và mình thấy đúng Vì chỉ mới tham gia chương trình của bác P hơn 3 tháng nên kết quả chưa được nhiều lắm Kết: đáng đồng tiền bác gạo Click to expand... rongdaen;108393929 said: cũng đang được chủ thớt tư vấn. trước khi đc tư vấn mình ở trong trạng thái nghĩ tới gái cả ngày lẫn đêm, thấy gái kêu đi chơi thì mừng húm chạy vội tới, và bị gái bơ vì vồ vập. sau khi đc chỉ điểm mình nhận ra giá trị cốt lõi của người đàn ông nằm ở lòng tự trọng và bản lĩnh. muốn chinh phục phụ nữ bạn phải là đàn ông thực thụ chứ không phải là trai mới lớn lẽo đẽo theo gái, chăm chăm xem gái muốn gì, nghĩ gì. muốn chinh phục mục tiêu có giá trị cao thì bạn cũng phải có giá trị tương đương Click to expand... meo.con.tam.nang;108675885 said: Em cũng đang dùng dịch vụ tư vấn của bác ManHoa nên review luôn cho các thím quan tâm. Em theo dõi thread này cũng lâu rồi, nhờ đọc các comment của bác ManHoa mà hiểu được nhiều khúc mắc trong cuộc sống và chuyện tình cảm. Bác ManHoa tư vấn cho em gần được nữa năm rồi. Cảm nhận chung là nhiệt tình và cực kỳ hiệu quả . Về chuyện tình cảm: Em trước ít nói, ngại giao tiếp. Giờ thì tự tin bắt chuyện với các bạn gái và tìm chủ đề để nói theo ý thích. Học thêm nhiều điều về lý giải cảm xúc và tâm lý của gái Về phát triển bản thân: thì đã tìm thấy niềm vui và động lực để làm việc. Đã tìm ra cách khắc phục bệnh hay trì hoãn. Dạo này đi làm cảm thấy vui vẻ, hứng khởi và hiệu quả hơn, chứ không chán chường như trước. Giá cả thì quá xứng đáng so với những gì dịch vụ tư vấn mang lại. Review nhanh cho các thím. Chúc các thím năm mới vui vẻ, vạn sự như ý. Click to expand... kbb.101;108761069 said: Cuối năm ko review dc, nên sẵn đầu năm coi như khai bút đầu xuân. Case mình sảy ra biến cố trùng hợp lúc topic này cũng vừa khai trương. Trong chuyện tình cảm trc h mình khá tự tin nhưng đến một lúc mình cũng bế tắc, tính buông xuôi thì gặp dc ông anh này. Ngó qua thì ông anh mới lên giá dịch vụ , nhưng yên tâm là số tiền bạn bỏ ra sẽ cho mọi người dc nhiều cái giá trị khác. Cách thức tư vấn thì theo mình khá hay, cho bạn hiểu dc nguyên do và hệ quả. Cũng như cách thức tác chiến cũng thú vị. kiểu như có ng mách nước, nhắc bài lúc trả bài ấy. Năm mới chúc mọi người thành đạt trong mọi lĩnh vực. Dm mọi người cái nhé Click to expand... Star Trek;108371517 said: Review sau 3 tuần sử dụng dịch vụ tư vấn phát triển bản thân Giá cả Phải chăng Thái độ Nhiệt tình Được tư vấn về - Cách xử lý trong một số tình huống giao tiếp cụ thể - Cách tạo động lực cho bản thân - Định hướng bản thân Mới sử dụng dịch vụ nên chưa rì viu được nhiều Click to expand... man_in_black;109718245 said: Sau 1 mùa ăn chơi tết nhất xong, đã comeback trở lại cuộc sống đời thường. Sẵn review dịch vụ của anh Man Hoa Luôn - Cái mà mình thích nhất ở anh Man Hoa là cái phân tích tâm lý, dự đoán dc bài của các em sẽ thế nào, Từ đó lên đối sách và plan phù hợp. Khúc nầy thì chỉ là dự phòng thôi. Còn lại củng phải tùy cơ ứng biến dựa vào thực lực cá nhân của các thím nữa. Còn làm sao để nâng cao thực lực cá nhân thì anh Man Hoa củng sẽ tư vấn cụ thể để các thím tự build bản thân lên - Ứng với mỗi người, anh Man Hoa sẽ có lời khuyên hợp lý tùy theo tình hình cá nhân và đối phương ra sao, Để có đối sách phù hợp. Kua gái là 1 quá trình hoàn thiện bản thân mình để tốt hơn chứ ko phải là 1 cái đích 1 người con gái nào khác đâu. Nên các thím phải chuẩn bị tin thần trước là sẽ dc anh Man Hoa chỉnh từ đầu tới chân để trở thành Manly đúng nghĩa nhé. Click to expand... tubakugan;135252453 said: [review dịch vụ]: Trước hết mình sorry anh Phong vì kết thúc dịch vụ đc gần nửa năm rồi mới cmt review (tại mải chiêm nghiệm những bài học của a quá + với đang học năm cuối nên cx ít time hóng voz như hồi trẻ trâu rảnh rỗi :v ) Trước khi biết và sd dịch vụ của anh thì cx có kinh qua kha khá các thớt tư vấn trên voz này. Điểm khác biệt rõ ràng và lớn nhất của a đó là tính khoa học và logic sâu sắc trong giải quyết vấn đề (không giống những người khác chỉ là thuật lại kinh nghiệm bản thân chứ không giải thích đc nguyên nhân - diễn biến - kết quả). Cảm giác khi đc anh tư vấn giống như ngồi nghe tư vấn của nhà nghiên cứu chuyên ngành về tâm sinh lí vậy :sexy: Các ví dụ, phân tích anh đưa ra trực quan, dễ hiểu và chứa một cái nhìn rất khách quan, đa chiều. Điều tâm đắc nhất mình thấm đc (dù đã có thể đọc qua trên voz nhưng k hiểu bản chất) đó là giá trị của người đàn ông đến từ nội lực và nỗ lực của bản thân, bất cứ mqh nào cx phải đc hình thành và xây dựng nên từ 2 phía, cho đi và nhận lại công bằng Chốt lại là dịch vụ của anh hoàn toàn hiệu quả và đáng tiền (có mỗi cái rep hơi chậm nhưng chắc là do anh phải xử lí nhiều case quá :chaymau Chúc anh năm mới có sức khoẻ để đồng hành hỗ trợ ae vozer thoát gà p.s: stalk đc a cx là trader, đang hold coin nào phím e với :sexy::sexy: Click to expand... runan1;138742673 said: Mình đã và đang sử dụng dịch vụ của bác ManHoa. Phải nói giá cả rẻ so với những gì mình nhận được. Từ một gã đụt, ăn nói nhảm, vô duyên, đùa cợt thô thiển vì vậy nên gái ko thích, mình đã trở thành một gã đàn ông chững chạc, biết ứng xử hợp lý, sắp tới sẽ là đàn ông đích thực Bác ManHoa đã từng bước chỉ cho mình các bài học, bài tập để cải thiện tính cách, cải thiện bản thân, điều đó đã giúp ích cho mình trong tình cảm, công việc cũng như cuộc sống. Sửa đổi tính cách tới tận gốc rễ luôn, kiểu học kiếm pháp để tạo ra kiếm chiêu, chứ ko phải kiểu gặp cái này phải làm thế này, gặp cái kia phải làm thế kia. Các bác voz nào mà nhát gái, giao tiếp kém, không biết ăn nói với gái như thế nào thì nên đăng ký một khóa học của bác ManHoa, đảm bảo sẽ tiến bộ rất nhiều, trở nên dạn dĩ, thu hút gái hơn.
  3. Jun 2022
    1. Ko dám nhận mình là ông Bố tốt vì còn khá nhiều tật xấu nhưng luôn dám nói ra và tự hào vì đã làm đc những việc này với 2 thằng con:- Chưa bao giờ nói hay gây áp lực với con là cần phải học giỏi, chỉ cần ko đội sổ, dốt nhất lớp là được.- Chưa bao giờ bắt con phải đi học thêm- Chưa bao giờ dạy con học chứ đừng nói là chửi mắng hay đánh đập khi nó không hiểu bài, 1 là mình ko có nghiệp vụ sư phạm, 2 nhận thức khác nhau và 3 là ko có nhu cầu con phải giỏi.- Chưa bao giờ khoe việc học của con lên mạng XH- Không cấm chơi điện tử nhưng có khống chế thời gian, ngày bình thường được chơi 30 phút, cuối tuần và ngày lễ đc chơi 1h nhưng trước khi chơi phải xem đúng từng đó thời gian một trong các loại phim khoa học, lịch sử, hạt giống tâm hồn ...- Đến bây giờ vẫn chưa cho dùng máy điện thoại.- Hỏi ý kiến và tôn trọng quyền quyết định, quyền sở hữu tài sản của con.Luôn động viên và dành thời gian làm cùng bọn nó:- Đọc nhiều sách- Vận động, chơi thể thao nhiều- Đi chơi du lịch và trải nghiệm nhiều (đi xa có gần có, sang chảnh có và ăn bờ ngủ bụi cũng có)- Nói về các công việc và cách kiếm tiền sau này- Xem các chương trình cùng bọn nó: bóng đá, Rap Việt, Chạy đi chờ chi, FapTV, TonyTV, Châu Tinh Trì, ca nhạc .v.v...Bố mẹ đừng gây áp lực cả tinh thần và thể xác với con cái khi muốn nó phải học giỏi, bắt nó phải đi học thêm triền miền, đừng tự dạy con học rồi nạt nộ, đánh đập khi nó ko hiểu bài nữa. Giỏi làm gì khi con trở thành gà công nghiệp, khi tâm lý bị ảnh hưởng nặng nề đến mức trầm cảm hay thậm chí là lấy đi tính mạng của con như rất nhiều trường hợp thương tâm gần đây. Ngày cuối năm đọc nhiều tin tức tiêu cực và thương tâm quá nên tâm sự tí, mong là Bố Mẹ nào đang vô tâm hành hạ con cái về cả tinh thần lẫn thể xác nhận ra điều đó và thay đổi sớm...692 Chau Thien Truc Quynh and 691 others65 Comments15 SharesLikeShare

      .

  4. Jul 2018
    1. On 2015 Nov 28, Friedrich Thinnes commented:

      Arguments for plasmalemmal VDAC-1 to form the channel part of VRAC

      The inclusion of VDAC-1 = voltage dependent anion channel of isotype-1 into the plasma membrane of mammalian cells was first demonstrated in 1989, this by its immuno-topochemical flagging on human B lymphocyte, and those data were meanwhile corroborated by several laboratories using manifold approaches world wide (1-4).

      Concerning the function of plasmalemmal VDAC-1 (5-9) it has been shown that the channel is involved in cell volume regulation. Cell outside applied monoclonal mouse anti-human type-1 porin antibodies blocked the RVD of HeLa cells, proving that VDAC-1 is involved in the process. HeLa cells pre-incubated with the antibodies dramatically increased their volume within about 1 min after a stimulus by hypotonic Ringer solution, but did not move backward towards their starting volume, thus indicating abolished RVD.

      To notice, corresponding blocking effects were induced by the established anion channel inhibitor DIDS or BH4BClXL peptides, respectively. Video camera monitoring of cell size over time was used in this direct and noninvasive approach (9; www.futhin.de Supplement 1). Corroboration of these data came from the laboratory of Dr. R. Boucher (10) using VDAC knock out mice, this study, furthermore, pointing to the channel as an ATP pathway.

      First data concerning the involvement of plasmalemmal VDAC-1 in the apoptotic process came from Dr. F. Elinder´s laboratory, demonstrating that opening of plasma membrane voltage-dependent anion channels (VDAC) precedes caspase activation in neuronal apoptosis induced by toxic stimuli (11). In line, the laboratory of Dr. Raquel Marin demonstrated that voltage dependent anion channel (VDAC-1) participates in amyloid Aß-induced toxicity and also interacts with the plasma membrane estrogen receptor alpha (mERa) in septal and hippocampal neurons (12). Noteworthy: Alzheimer Disease disproportionally affects women.

      To notice, plasmalemmal VDAC and amyloid Aß, too, carry GxxxG peptide interaction motifs (2-4).

      Concerning VDAC-1 agonists there are many data on low molecular weight agonists working on VDAC in varying settings, which may be helpful in studies on VRAC: DIDS, cholesterol, ATP, König's polyanion, dextran sulfate, Ga3+, Al3+, Zn2+, polyamines, compound 48/80, ruthenium red, fluoxetine, cisplatin, curcumin. Further studies looked for corresponding effect of peptides e.g. BH4-BClXL peptides, peptides including the free N-terminal part of VDAC-1 and amyloid Aβ peptides (4,9-16).

      There is increasing evidence on interactions of VDAC-1 and proteineous modulators: e.g. α-synuclein shows high affinity interaction with voltage dependent anion channel, suggesting mechanisms of regulation and toxicity in Parkinson Disease (17). It has, furthermore, been shown that interaction of human plasminogen kringle 5 and plasmalemmal VDAC-1 links the channel to the extrinsic apoptotic pathway (18). Finally, an early study pointed to cancer cell cycle modulation by functional coupling between sigma-1 receptors and Cl- channels, here GxxxG motifs putatively playing a role (19,20).

      Noteworthy, a SwissProt alignment of the LRC8A-D sequences shows two GxxxG motifs in a critical loop of LRC8E (Thinnes, unpublished).

      Conclusion

      While the expression of VDAC-1 in in the plasma membranes is beyond reasonable doubt (1-4) its function in this compartment is still in debate (5-20, 21-23).

      VDAC-1 shows ubiquitous multi-toplogical expression, standing in outer mitochondrial membranes, the endoplasmic reticulum, as well as in the plasmalemma. To fulfill putatively varying functions in differing compartments, from the beginning on, my laboratory postulated proteineous channel modulators, which in varying heteromer complexes may adjust membrane-standing VDAC-1 to local needs.

      Meanwhile, several of those come to the fore. VRAC/VSOAC candidates appear to be amongst them.

      Finally, concerning medical relevance VDAC-1 complexes are involved in the pathogenesis of e.g. Cystic Fibrosis (13), Alzheimer Disease (3,4,12) and cancer (4).

      References

      1) De Pinto V, Messina A, Lane DJ, Lawen A. FEBS Lett. 2010 May 3;584(9):1793-9. doi: 10.1016/j.febslet.2010.02.049. Epub 2010 Feb 23. Review. PMID: 20184885 Free Article

      2) Thinnes FP. Biochim Biophys Acta. 2015 Jun;1848(6):1410-6. doi: 10.1016/j.bbamem.2015.02.031. Epub 2015 Mar 11. Review. PMID: 25771449

      3) Thinnes FP. Front Aging Neurosci. 2015 Sep 30;7:188. doi: 10.3389/fnagi.2015.00188. eCollection 2015. No abstract available. PMID: 26483684 Free PMC Article

      4) Smilansky A, Dangoor L, Nakdimon I, Ben-Hail D, Mizrachi D, Shoshan-Barmatz V. J Biol Chem. 2015 Nov 5. pii: jbc.M115.691493. [Epub ahead of print] PMID: 26542804 Free Article

      5) Morris AP, Frizzell RA. Am J Physiol. 1993 Apr;264(4 Pt 1):C977-85. PMID: 7682780

      6) Blatz AL, Magleby KL. Biophys J. 1983 Aug;43(2):237-41. PMID: 6311302 Free PMC Article

      7) Dermietzel R, Hwang TK, Buettner R, Hofer A, Dotzler E, Kremer M, Deutzmann R, Thinnes FP, Fishman GI, Spray DC, et al. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):499-503. PMID: 7507248 Free PMC Article

      8) Schwiebert EM, Egan ME, Hwang TH, Fulmer SB, Allen SS, Cutting GR, Guggino WB. Cell. 1995 Jun 30;81(7):1063-73. PMID: 7541313 Free Article

      9) Thinnes FP, Hellmann KP, Hellmann T, Merker R, Brockhaus-Pruchniewicz U, Schwarzer C, Walter G, Götz H, Hilschmann N. Mol Genet Metab. 2000 Apr;69(4):331-7. PMID: 10870851 10) Okada SF, O'Neal WK, Huang P, Nicholas RA, Ostrowski LE, Craigen WJ, Lazarowski ER, Boucher RC. J Gen Physiol. 2004 Nov;124(5):513-26. Epub 2004 Oct 11. PMID: 15477379 Free PMC Article

      11a) Elinder F, Akanda N, Tofighi R, Shimizu S, Tsujimoto Y, Orrenius S, Ceccatelli S. Cell Death Differ. 2005 Aug;12(8):1134-40. PMID: 15861186 Free Article

      11b) Akanda N, Tofighi R, Brask J, Tamm C, Elinder F, Ceccatelli S. Cell Cycle. 2008 Oct; 7(20):3225-34. Epub 2008 Oct 20. PMID: 18927501

      12a) Marin R, Ramírez CM, González M, González-Muñoz E, Zorzano A, Camps M, Alonso R, Díaz M. Mol Membr Biol. 2007 Mar-Apr;24(2):148-60. PMID: 17453421

      12b) Herrera JL, Diaz M, Hernández-Fernaud JR, Salido E, Alonso R, Fernández C, Morales A, Marin R. J Neurochem. 2011 Mar;116(5):820-7. doi: 10.1111/j.1471-4159.2010.06987.x. Epub 2011 Jan 7. Review. PMID: 21214547 Free Article

      13) Thinnes FP. Mol Genet Metab. 2014 Apr;111(4):439-44. doi: 10.1016/j.ymgme.2014.02.001. Epub 2014 Feb 13. Review. PMID: 24613483

      14 Thinnes FP. PMID: 15781203 [PubMed - indexed for MEDLINE] Mol Genet Metab. 2005 Apr;84(4):378.

      15) Thinnes FP. Mol Genet Metab. 2009 Jun;97(2):163. doi: 10.1016/j.ymgme.2009.01.014. Epub 2009 Feb 3. No abstract available. PMID: 19251445

      16) Thinnes FP. Am J Physiol Cell Physiol. 2010 May;298(5):C1276. doi: 10.1152/ajpcell.00032.2010. No abstract available. PMID: 20413797 Free Article

      17) Rostovtseva TK, Gurnev PA, Protchenko O, Hoogerheide DP, Yap TL, Philpott CC, Lee JC, Bezrukov SM. J Biol Chem. 2015 Jul 24;290(30):18467-77. doi: 10.1074/jbc.M115.641746. Epub 2015 Jun 8. PMID: 26055708

      18) Li L, Yao YC, Gu XQ, Che D, Ma CQ, Dai ZY, Li C, Zhou T, Cai WB, Yang ZH, Yang X, Gao GQ. J Biol Chem. 2014 Nov 21;289(47):32628-38. doi: 10.1074/jbc.M114.567792. Epub 2014 Oct 8. PMID: 25296756 Free PMC Article

      19) Renaudo A, L'Hoste S, Guizouarn H, Borgèse F, Soriani O. J Biol Chem. 2007 Jan 26;282(4):2259-67. Epub 2006 Nov 22. PMID: 17121836 Free Article

      20) Chu U, Ruoho AE. Mol Pharmacol. 2015 Nov 11. pii: mol.115.101170. [Epub ahead of print] PMID: 26560551 Free Article

      21) Liu HT, Tashmukhamedov BA, Inoue H, Okada Y, Sabirov RZ. Glia. 2006 Oct;54(5):343-57. Erratum in: Glia. 2006 Dec;54(8):891.

      22) Sabirov RZ, Merzlyak PG. Biochim Biophys Acta. 2012 Jun;1818(6):1570-80. doi: 10.1016/j.bbamem.2011.09.024. Epub 2011 Oct 1. Review. PMID: 21986486 Free Article

      23) Pedersen SF, Klausen TK, Nilius B. Acta Physiol (Oxf). 2015 Apr;213(4):868-81. doi: 10.1111/apha.12450. Epub 2015 Jan 28.


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.

  5. Feb 2018
    1. On 2015 Nov 28, Friedrich Thinnes commented:

      Arguments for plasmalemmal VDAC-1 to form the channel part of VRAC

      The inclusion of VDAC-1 = voltage dependent anion channel of isotype-1 into the plasma membrane of mammalian cells was first demonstrated in 1989, this by its immuno-topochemical flagging on human B lymphocyte, and those data were meanwhile corroborated by several laboratories using manifold approaches world wide (1-4).

      Concerning the function of plasmalemmal VDAC-1 (5-9) it has been shown that the channel is involved in cell volume regulation. Cell outside applied monoclonal mouse anti-human type-1 porin antibodies blocked the RVD of HeLa cells, proving that VDAC-1 is involved in the process. HeLa cells pre-incubated with the antibodies dramatically increased their volume within about 1 min after a stimulus by hypotonic Ringer solution, but did not move backward towards their starting volume, thus indicating abolished RVD.

      To notice, corresponding blocking effects were induced by the established anion channel inhibitor DIDS or BH4BClXL peptides, respectively. Video camera monitoring of cell size over time was used in this direct and noninvasive approach (9; www.futhin.de Supplement 1). Corroboration of these data came from the laboratory of Dr. R. Boucher (10) using VDAC knock out mice, this study, furthermore, pointing to the channel as an ATP pathway.

      First data concerning the involvement of plasmalemmal VDAC-1 in the apoptotic process came from Dr. F. Elinder´s laboratory, demonstrating that opening of plasma membrane voltage-dependent anion channels (VDAC) precedes caspase activation in neuronal apoptosis induced by toxic stimuli (11). In line, the laboratory of Dr. Raquel Marin demonstrated that voltage dependent anion channel (VDAC-1) participates in amyloid Aß-induced toxicity and also interacts with the plasma membrane estrogen receptor alpha (mERa) in septal and hippocampal neurons (12). Noteworthy: Alzheimer Disease disproportionally affects women.

      To notice, plasmalemmal VDAC and amyloid Aß, too, carry GxxxG peptide interaction motifs (2-4).

      Concerning VDAC-1 agonists there are many data on low molecular weight agonists working on VDAC in varying settings, which may be helpful in studies on VRAC: DIDS, cholesterol, ATP, König's polyanion, dextran sulfate, Ga3+, Al3+, Zn2+, polyamines, compound 48/80, ruthenium red, fluoxetine, cisplatin, curcumin. Further studies looked for corresponding effect of peptides e.g. BH4-BClXL peptides, peptides including the free N-terminal part of VDAC-1 and amyloid Aβ peptides (4,9-16).

      There is increasing evidence on interactions of VDAC-1 and proteineous modulators: e.g. α-synuclein shows high affinity interaction with voltage dependent anion channel, suggesting mechanisms of regulation and toxicity in Parkinson Disease (17). It has, furthermore, been shown that interaction of human plasminogen kringle 5 and plasmalemmal VDAC-1 links the channel to the extrinsic apoptotic pathway (18). Finally, an early study pointed to cancer cell cycle modulation by functional coupling between sigma-1 receptors and Cl- channels, here GxxxG motifs putatively playing a role (19,20).

      Noteworthy, a SwissProt alignment of the LRC8A-D sequences shows two GxxxG motifs in a critical loop of LRC8E (Thinnes, unpublished).

      Conclusion

      While the expression of VDAC-1 in in the plasma membranes is beyond reasonable doubt (1-4) its function in this compartment is still in debate (5-20, 21-23).

      VDAC-1 shows ubiquitous multi-toplogical expression, standing in outer mitochondrial membranes, the endoplasmic reticulum, as well as in the plasmalemma. To fulfill putatively varying functions in differing compartments, from the beginning on, my laboratory postulated proteineous channel modulators, which in varying heteromer complexes may adjust membrane-standing VDAC-1 to local needs.

      Meanwhile, several of those come to the fore. VRAC/VSOAC candidates appear to be amongst them.

      Finally, concerning medical relevance VDAC-1 complexes are involved in the pathogenesis of e.g. Cystic Fibrosis (13), Alzheimer Disease (3,4,12) and cancer (4).

      References

      1) De Pinto V, Messina A, Lane DJ, Lawen A. FEBS Lett. 2010 May 3;584(9):1793-9. doi: 10.1016/j.febslet.2010.02.049. Epub 2010 Feb 23. Review. PMID: 20184885 Free Article

      2) Thinnes FP. Biochim Biophys Acta. 2015 Jun;1848(6):1410-6. doi: 10.1016/j.bbamem.2015.02.031. Epub 2015 Mar 11. Review. PMID: 25771449

      3) Thinnes FP. Front Aging Neurosci. 2015 Sep 30;7:188. doi: 10.3389/fnagi.2015.00188. eCollection 2015. No abstract available. PMID: 26483684 Free PMC Article

      4) Smilansky A, Dangoor L, Nakdimon I, Ben-Hail D, Mizrachi D, Shoshan-Barmatz V. J Biol Chem. 2015 Nov 5. pii: jbc.M115.691493. [Epub ahead of print] PMID: 26542804 Free Article

      5) Morris AP, Frizzell RA. Am J Physiol. 1993 Apr;264(4 Pt 1):C977-85. PMID: 7682780

      6) Blatz AL, Magleby KL. Biophys J. 1983 Aug;43(2):237-41. PMID: 6311302 Free PMC Article

      7) Dermietzel R, Hwang TK, Buettner R, Hofer A, Dotzler E, Kremer M, Deutzmann R, Thinnes FP, Fishman GI, Spray DC, et al. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):499-503. PMID: 7507248 Free PMC Article

      8) Schwiebert EM, Egan ME, Hwang TH, Fulmer SB, Allen SS, Cutting GR, Guggino WB. Cell. 1995 Jun 30;81(7):1063-73. PMID: 7541313 Free Article

      9) Thinnes FP, Hellmann KP, Hellmann T, Merker R, Brockhaus-Pruchniewicz U, Schwarzer C, Walter G, Götz H, Hilschmann N. Mol Genet Metab. 2000 Apr;69(4):331-7. PMID: 10870851 10) Okada SF, O'Neal WK, Huang P, Nicholas RA, Ostrowski LE, Craigen WJ, Lazarowski ER, Boucher RC. J Gen Physiol. 2004 Nov;124(5):513-26. Epub 2004 Oct 11. PMID: 15477379 Free PMC Article

      11a) Elinder F, Akanda N, Tofighi R, Shimizu S, Tsujimoto Y, Orrenius S, Ceccatelli S. Cell Death Differ. 2005 Aug;12(8):1134-40. PMID: 15861186 Free Article

      11b) Akanda N, Tofighi R, Brask J, Tamm C, Elinder F, Ceccatelli S. Cell Cycle. 2008 Oct; 7(20):3225-34. Epub 2008 Oct 20. PMID: 18927501

      12a) Marin R, Ramírez CM, González M, González-Muñoz E, Zorzano A, Camps M, Alonso R, Díaz M. Mol Membr Biol. 2007 Mar-Apr;24(2):148-60. PMID: 17453421

      12b) Herrera JL, Diaz M, Hernández-Fernaud JR, Salido E, Alonso R, Fernández C, Morales A, Marin R. J Neurochem. 2011 Mar;116(5):820-7. doi: 10.1111/j.1471-4159.2010.06987.x. Epub 2011 Jan 7. Review. PMID: 21214547 Free Article

      13) Thinnes FP. Mol Genet Metab. 2014 Apr;111(4):439-44. doi: 10.1016/j.ymgme.2014.02.001. Epub 2014 Feb 13. Review. PMID: 24613483

      14 Thinnes FP. PMID: 15781203 [PubMed - indexed for MEDLINE] Mol Genet Metab. 2005 Apr;84(4):378.

      15) Thinnes FP. Mol Genet Metab. 2009 Jun;97(2):163. doi: 10.1016/j.ymgme.2009.01.014. Epub 2009 Feb 3. No abstract available. PMID: 19251445

      16) Thinnes FP. Am J Physiol Cell Physiol. 2010 May;298(5):C1276. doi: 10.1152/ajpcell.00032.2010. No abstract available. PMID: 20413797 Free Article

      17) Rostovtseva TK, Gurnev PA, Protchenko O, Hoogerheide DP, Yap TL, Philpott CC, Lee JC, Bezrukov SM. J Biol Chem. 2015 Jul 24;290(30):18467-77. doi: 10.1074/jbc.M115.641746. Epub 2015 Jun 8. PMID: 26055708

      18) Li L, Yao YC, Gu XQ, Che D, Ma CQ, Dai ZY, Li C, Zhou T, Cai WB, Yang ZH, Yang X, Gao GQ. J Biol Chem. 2014 Nov 21;289(47):32628-38. doi: 10.1074/jbc.M114.567792. Epub 2014 Oct 8. PMID: 25296756 Free PMC Article

      19) Renaudo A, L'Hoste S, Guizouarn H, Borgèse F, Soriani O. J Biol Chem. 2007 Jan 26;282(4):2259-67. Epub 2006 Nov 22. PMID: 17121836 Free Article

      20) Chu U, Ruoho AE. Mol Pharmacol. 2015 Nov 11. pii: mol.115.101170. [Epub ahead of print] PMID: 26560551 Free Article

      21) Liu HT, Tashmukhamedov BA, Inoue H, Okada Y, Sabirov RZ. Glia. 2006 Oct;54(5):343-57. Erratum in: Glia. 2006 Dec;54(8):891.

      22) Sabirov RZ, Merzlyak PG. Biochim Biophys Acta. 2012 Jun;1818(6):1570-80. doi: 10.1016/j.bbamem.2011.09.024. Epub 2011 Oct 1. Review. PMID: 21986486 Free Article

      23) Pedersen SF, Klausen TK, Nilius B. Acta Physiol (Oxf). 2015 Apr;213(4):868-81. doi: 10.1111/apha.12450. Epub 2015 Jan 28.


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.